ONTOLOGY REPORT - ANNOTATIONS
| Term: | amiodarone |
|
| Accession: | CHEBI:2663
|
browse the term
|
| Definition: | An organoiodine compound that has formula C25H29I2NO3. |
| Synonyms: | exact_synonym: | (2-butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone |
| | related_synonym: | 2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran; 2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone; 2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran; C25H29I2NO3; CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1; InChI=1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3; InChIKey=IYIKLHRQXLHMJQ-UHFFFAOYSA-N |
| | xref_casrn: | 1951-25-3 |
| | xref: | Beilstein:1271711 "Beilstein Registry Number"; ChEMBL:127185 "ChEMBL COMPOUND"; ChemIDplus:1951-25-3 "CAS Registry Number"; DrugBank:DB01118 "DrugBank"; KEGG COMPOUND:1951-25-3 "CAS Registry Number"; KEGG COMPOUND:C06823 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D000638 |
| | xref: | Wikipedia:Amiodarone "Wikipedia" |
|
|
amiodarone
|
| G |
AADAT |
aminoadipate aminotransferase |
|
affects expression |
ISO |
4 |
170,981,373 |
171,011,372 |
RGD:6480464 |
CTD |
| G |
ABCA2 |
ATP-binding cassette, sub-family A (ABC1), member 2 |
|
increases expression |
EXP |
9 |
139,901,686 |
139,923,374 |
RGD:6480464 |
CTD |
| G |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
|
multiple interactions |
EXP |
7 |
87,133,179 |
87,342,639 |
RGD:6480464 |
CTD |
| G |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
|
decreases activity |
EXP |
7 |
87,133,179 |
87,342,639 |
RGD:6480464 |
CTD |
| G |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
|
affects expression |
ISO |
7 |
87,133,179 |
87,342,639 |
RGD:6480464 |
CTD |
| G |
ABCB11 |
ATP-binding cassette, sub-family B (MDR/TAP), member 11 |
|
decreases activity |
EXP |
2 |
169,779,449 |
169,887,833 |
RGD:6480464 |
CTD |
| G |
ABCC11 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 11 |
|
increases expression |
EXP |
16 |
48,200,822 |
48,269,088 |
RGD:6480464 |
CTD |
| G |
ABCC6 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
|
affects expression |
ISO |
16 |
16,243,422 |
16,317,328 |
RGD:6480464 |
CTD |
| G |
ABCG5 |
ATP-binding cassette, sub-family G (WHITE), member 5 |
|
affects expression |
ISO |
2 |
44,039,611 |
44,065,958 |
RGD:6480464 |
CTD |
| G |
ABHD1 |
abhydrolase domain containing 1 |
|
affects expression |
ISO |
2 |
27,346,657 |
27,353,680 |
RGD:6480464 |
CTD |
| G |
ABHD14B |
abhydrolase domain containing 14B |
|
affects expression |
ISO |
3 |
52,002,526 |
52,008,646 |
RGD:6480464 |
CTD |
| G |
ABHD17A |
abhydrolase domain containing 17A |
|
affects expression |
ISO |
19 |
1,876,975 |
1,885,518 |
RGD:6480464 |
CTD |
| G |
ABL1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
increases expression |
EXP |
9 |
133,589,268 |
133,763,062 |
RGD:6480464 |
CTD |
| G |
ACAA1 |
acetyl-CoA acyltransferase 1 |
|
increases expression |
ISO |
3 |
38,164,201 |
38,178,733 |
RGD:6480464 |
CTD |
| G |
ACACA |
acetyl-CoA carboxylase alpha |
|
affects expression |
ISO |
17 |
35,441,927 |
35,766,902 |
RGD:6480464 |
CTD |
| G |
ACACA |
acetyl-CoA carboxylase alpha |
|
increases expression |
EXP |
17 |
35,441,927 |
35,766,902 |
RGD:6480464 |
CTD |
| G |
ACACB |
acetyl-CoA carboxylase beta |
|
increases expression |
ISO |
12 |
109,577,202 |
109,706,031 |
RGD:6480464 |
CTD |
| G |
ACADL |
acyl-CoA dehydrogenase, long chain |
|
affects expression |
ISO |
2 |
211,052,714 |
211,090,215 |
RGD:6480464 |
CTD |
| G |
ACO1 |
aconitase 1, soluble |
|
affects expression |
ISO |
9 |
32,384,601 |
32,450,834 |
RGD:6480464 |
CTD |
| G |
ACO2 |
aconitase 2, mitochondrial |
|
affects expression |
ISO |
22 |
41,865,129 |
41,924,993 |
RGD:6480464 |
CTD |
| G |
ACOT12 |
acyl-CoA thioesterase 12 |
|
affects expression |
ISO |
5 |
80,625,947 |
80,689,988 |
RGD:6480464 |
CTD |
| G |
ACOT4 |
acyl-CoA thioesterase 4 |
|
affects expression |
ISO |
14 |
74,058,410 |
74,062,470 |
RGD:6480464 |
CTD |
| G |
ACOT8 |
acyl-CoA thioesterase 8 |
|
increases expression |
EXP |
20 |
44,470,360 |
44,486,048 |
RGD:6480464 |
CTD |
| G |
ACOX1 |
acyl-CoA oxidase 1, palmitoyl |
|
increases expression |
ISO |
17 |
73,937,588 |
73,975,515 |
RGD:6480464 |
CTD |
| G |
ACSF3 |
acyl-CoA synthetase family member 3 |
|
increases expression |
EXP |
16 |
89,160,217 |
89,222,171 |
RGD:6480464 |
CTD |
| G |
ACTR3B |
ARP3 actin-related protein 3 homolog B (yeast) |
|
increases expression |
EXP |
7 |
152,456,834 |
152,552,464 |
RGD:6480464 |
CTD |
| G |
ACVR1B |
activin A receptor, type IB |
|
increases expression |
EXP |
12 |
52,345,451 |
52,390,863 |
RGD:6480464 |
CTD |
| G |
ACYP1 |
acylphosphatase 1, erythrocyte (common) type |
|
increases expression |
EXP |
14 |
75,519,924 |
75,530,736 |
RGD:6480464 |
CTD |
| G |
ADAM15 |
ADAM metallopeptidase domain 15 |
|
affects expression |
ISO |
1 |
155,023,748 |
155,035,252 |
RGD:6480464 |
CTD |
| G |
ADD1 |
adducin 1 (alpha) |
|
affects expression |
ISO |
4 |
2,845,584 |
2,931,803 |
RGD:6480464 |
CTD |
| G |
ADH4 |
alcohol dehydrogenase 4 (class II), pi polypeptide |
|
affects expression |
ISO |
4 |
100,044,832 |
100,065,449 |
RGD:6480464 |
CTD |
| G |
ADRB1 |
adrenoceptor beta 1 |
|
decreases expression |
EXP |
10 |
115,803,806 |
115,806,667 |
RGD:6480464 |
CTD |
| G |
ADRB2 |
adrenoceptor beta 2, surface |
|
decreases expression |
EXP |
5 |
148,206,156 |
148,208,197 |
RGD:6480464 |
CTD |
| G |
ADTRP |
androgen-dependent TFPI-regulating protein |
|
affects expression |
ISO |
6 |
11,713,888 |
11,779,280 |
RGD:6480464 |
CTD |
| G |
ANXA4 |
annexin A4 |
|
increases expression |
EXP |
2 |
69,969,127 |
70,053,596 |
RGD:6480464 |
CTD |
| G |
AP1S1 |
adaptor-related protein complex 1, sigma 1 subunit |
|
decreases expression |
EXP |
7 |
100,797,686 |
100,804,557 |
RGD:6480464 |
CTD |
| G |
AP2M1 |
adaptor-related protein complex 2, mu 1 subunit |
|
affects expression |
ISO |
3 |
183,892,634 |
183,901,879 |
RGD:6480464 |
CTD |
| G |
APOA4 |
apolipoprotein A-IV |
|
affects expression |
ISO |
11 |
116,691,418 |
116,694,011 |
RGD:6480464 |
CTD |
| G |
APOE |
apolipoprotein E |
|
decreases expression |
ISO |
19 |
45,409,039 |
45,412,650 |
RGD:6480464 |
CTD |
| G |
APOH |
apolipoprotein H (beta-2-glycoprotein I) |
|
affects expression |
ISO |
17 |
64,208,147 |
64,225,556 |
RGD:6480464 |
CTD |
| G |
APOOL |
apolipoprotein O-like |
|
affects expression |
ISO |
X |
84,258,898 |
84,348,323 |
RGD:6480464 |
CTD |
| G |
ARC |
activity-regulated cytoskeleton-associated protein |
|
increases expression |
EXP |
8 |
143,692,405 |
143,695,833 |
RGD:6480464 |
CTD |
| G |
ARG1 |
arginase, liver |
|
affects expression |
ISO |
6 |
131,894,344 |
131,905,472 |
RGD:6480464 |
CTD |
| G |
ARHGAP15 |
Rho GTPase activating protein 15 |
|
increases expression |
EXP |
2 |
143,886,899 |
144,525,921 |
RGD:6480464 |
CTD |
| G |
ARHGAP35 |
Rho GTPase activating protein 35 |
|
increases expression |
EXP |
19 |
47,421,933 |
47,508,334 |
RGD:6480464 |
CTD |
| G |
ARHGAP4 |
Rho GTPase activating protein 4 |
|
increases expression |
EXP |
X |
153,172,830 |
153,191,714 |
RGD:6480464 |
CTD |
| G |
ARHGAP9 |
Rho GTPase activating protein 9 |
|
increases expression |
EXP |
12 |
57,866,038 |
57,873,633 |
RGD:6480464 |
CTD |
| G |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
|
increases expression |
EXP |
1 |
17,866,330 |
18,024,370 |
RGD:6480464 |
CTD |
| G |
ARHGEF7 |
Rho guanine nucleotide exchange factor (GEF) 7 |
|
increases expression |
EXP |
13 |
111,767,624 |
111,958,081 |
RGD:6480464 |
CTD |
| G |
ARHGEF9 |
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
|
increases expression |
EXP |
X |
62,854,848 |
63,005,426 |
RGD:6480464 |
CTD |
| G |
ARID5A |
AT rich interactive domain 5A (MRF1-like) |
|
increases expression |
EXP |
2 |
97,202,464 |
97,218,371 |
RGD:6480464 |
CTD |
| G |
ARL6IP1 |
ADP-ribosylation factor-like 6 interacting protein 1 |
|
affects expression |
ISO |
16 |
18,802,991 |
18,812,857 |
RGD:6480464 |
CTD |
| G |
ARMC9 |
armadillo repeat containing 9 |
|
increases expression |
EXP |
2 |
232,063,294 |
232,238,606 |
RGD:6480464 |
CTD |
| G |
ARPC4 |
actin related protein 2/3 complex, subunit 4, 20kDa |
|
increases expression |
EXP |
3 |
9,834,179 |
9,848,789 |
RGD:6480464 |
CTD |
| G |
ASAH1 |
N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
|
increases expression |
ISO |
8 |
17,913,925 |
17,942,507 |
RGD:6480464 |
CTD |
| G |
ASAH1 |
N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
|
increases expression |
EXP |
8 |
17,913,925 |
17,942,507 |
RGD:6480464 |
CTD |
| G |
ASB7 |
ankyrin repeat and SOCS box containing 7 |
|
increases expression |
EXP |
15 |
101,142,755 |
101,191,906 |
RGD:6480464 |
CTD |
| G |
ASGR2 |
asialoglycoprotein receptor 2 |
|
affects expression |
ISO |
17 |
7,004,641 |
7,018,130 |
RGD:6480464 |
CTD |
| G |
ASNS |
asparagine synthetase (glutamine-hydrolyzing) |
|
increases expression |
EXP |
7 |
97,481,429 |
97,501,854 |
RGD:6480464 |
CTD |
| G |
ATF3 |
activating transcription factor 3 |
|
increases expression |
EXP |
1 |
212,738,676 |
212,794,119 |
RGD:6480464 |
CTD |
| G |
ATF4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
increases expression |
EXP |
22 |
39,916,569 |
39,918,691 |
RGD:6480464 |
CTD |
| G |
ATF5 |
activating transcription factor 5 |
|
affects expression |
ISO |
19 |
50,431,959 |
50,437,193 |
RGD:6480464 |
CTD |
| G |
ATF6B |
activating transcription factor 6 beta |
|
increases expression |
EXP |
6 |
32,083,045 |
32,096,017 |
RGD:6480464 |
CTD |
| G |
ATOH1 |
atonal homolog 1 (Drosophila) |
|
increases expression |
EXP |
4 |
94,750,078 |
94,751,142 |
RGD:6480464 |
CTD |
| G |
ATP11C |
ATPase, class VI, type 11C |
|
increases expression |
EXP |
X |
138,808,505 |
138,914,447 |
RGD:6480464 |
CTD |
| G |
ATP1A1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
decreases expression |
ISO |
1 |
116,915,795 |
116,947,396 |
RGD:6480464 |
CTD |
| G |
ATP1A2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
decreases expression |
ISO |
1 |
160,085,520 |
160,113,381 |
RGD:6480464 |
CTD |
| G |
ATP1A2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
decreases expression |
ISO |
1 |
160,085,520 |
160,113,381 |
RGD:6480464 |
CTD |
| G |
ATP1B1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
decreases expression |
ISO |
1 |
169,075,947 |
169,101,960 |
RGD:6480464 |
CTD |
| G |
ATP1B2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
|
decreases expression |
ISO |
17 |
7,554,254 |
7,561,089 |
RGD:6480464 |
CTD |
| G |
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression |
ISO |
12 |
110,719,032 |
110,788,898 |
RGD:6480464 |
CTD |
| G |
ATP5B |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
increases expression |
ISO |
12 |
57,031,959 |
57,039,852 |
RGD:6480464 |
CTD |
| G |
ATP5E |
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit |
|
affects expression |
ISO |
20 |
57,603,733 |
57,607,422 |
RGD:6480464 |
CTD |
| G |
ATP5S |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit s (factor B) |
|
affects expression |
ISO |
14 |
50,779,047 |
50,792,960 |
RGD:6480464 |
CTD |
| G |
ATP6AP2 |
ATPase, H+ transporting, lysosomal accessory protein 2 |
|
affects expression |
ISO |
X |
40,440,216 |
40,465,889 |
RGD:6480464 |
CTD |
| G |
ATP6V1A |
ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A |
|
affects expression |
ISO |
3 |
113,465,866 |
113,530,905 |
RGD:6480464 |
CTD |
| G |
ATP6V1F |
ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F |
|
affects expression |
ISO |
7 |
128,502,857 |
128,505,903 |
RGD:6480464 |
CTD |
| G |
BAAT |
bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) |
|
affects expression |
ISO |
9 |
104,122,699 |
104,147,287 |
RGD:6480464 |
CTD |
| G |
BAG1 |
BCL2-associated athanogene |
|
increases expression |
EXP |
9 |
33,252,469 |
33,264,759 |
RGD:6480464 |
CTD |
| G |
BAG3 |
BCL2-associated athanogene 3 |
|
decreases expression |
ISO |
10 |
121,410,882 |
121,437,331 |
RGD:6480464 |
CTD |
| G |
BAIAP2L1 |
BAI1-associated protein 2-like 1 |
|
increases expression |
EXP |
7 |
97,920,962 |
98,030,427 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BBOX1 |
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
|
increases expression |
EXP |
11 |
27,062,509 |
27,149,354 |
RGD:6480464 |
CTD |
| G |
BCKDHA |
branched chain keto acid dehydrogenase E1, alpha polypeptide |
|
increases expression |
ISO |
19 |
41,903,694 |
41,930,910 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2L11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
EXP |
2 |
111,878,491 |
111,926,022 |
RGD:6480464 |
CTD |
| G |
BCL6B |
B-cell CLL/lymphoma 6, member B |
|
affects expression |
ISO |
17 |
6,926,369 |
6,932,961 |
RGD:6480464 |
CTD |
| G |
BHLHE40 |
basic helix-loop-helix family, member e40 |
|
increases expression |
EXP |
3 |
5,021,097 |
5,026,866 |
RGD:6480464 |
CTD |
| G |
BHMT |
betaine--homocysteine S-methyltransferase |
|
affects expression |
ISO |
5 |
78,407,604 |
78,428,113 |
RGD:6480464 |
CTD |
| G |
BID |
BH3 interacting domain death agonist |
|
multiple interactions |
EXP |
22 |
18,216,906 |
18,257,431 |
RGD:6480464 |
CTD |
| G |
BIRC5 |
baculoviral IAP repeat containing 5 |
|
decreases expression |
ISO |
17 |
76,210,277 |
76,221,716 |
RGD:6480464 |
CTD |
| G |
BMF |
Bcl2 modifying factor |
|
affects expression |
ISO |
15 |
40,380,091 |
40,401,075 |
RGD:6480464 |
CTD |
| G |
BMP2K |
BMP2 inducible kinase |
|
increases expression |
EXP |
4 |
79,697,532 |
79,833,341 |
RGD:6480464 |
CTD |
| G |
BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
|
affects expression |
ISO |
10 |
133,781,204 |
133,795,435 |
RGD:6480464 |
CTD |
| G |
BOLA2 |
bolA homolog 2 (E. coli) |
|
increases expression |
EXP |
16 |
29,464,914 |
29,466,285 |
RGD:6480464 |
CTD |
| G |
BOLL |
bol, boule-like (Drosophila) |
|
increases expression |
EXP |
2 |
198,591,603 |
198,650,938 |
RGD:6480464 |
CTD |
| G |
BRCC3 |
BRCA1/BRCA2-containing complex, subunit 3 |
|
increases expression |
EXP |
X |
154,299,695 |
154,351,349 |
RGD:6480464 |
CTD |
| G |
BRPF1 |
bromodomain and PHD finger containing, 1 |
|
increases expression |
EXP |
3 |
9,773,434 |
9,789,699 |
RGD:6480464 |
CTD |
| G |
BSG |
basigin (Ok blood group) |
|
increases expression |
EXP |
19 |
571,277 |
583,493 |
RGD:6480464 |
CTD |
| G |
BTF3 |
basic transcription factor 3 |
|
affects expression |
ISO |
5 |
72,794,250 |
72,801,448 |
RGD:6480464 |
CTD |
| G |
C11orf16 |
chromosome 11 open reading frame 16 |
|
increases expression |
EXP |
11 |
8,941,623 |
8,954,553 |
RGD:6480464 |
CTD |
| G |
C16orf74 |
chromosome 16 open reading frame 74 |
|
increases expression |
EXP |
16 |
85,741,123 |
85,784,689 |
RGD:6480464 |
CTD |
| G |
C1orf95 |
chromosome 1 open reading frame 95 |
|
increases expression |
EXP |
1 |
226,736,501 |
226,796,915 |
RGD:6480464 |
CTD |
| G |
C1QBP |
complement component 1, q subcomponent binding protein |
|
affects expression |
ISO |
17 |
5,336,099 |
5,342,471 |
RGD:6480464 |
CTD |
| G |
C1S |
complement component 1, s subcomponent |
|
affects expression |
ISO |
12 |
7,167,980 |
7,178,336 |
RGD:6480464 |
CTD |
| G |
C20orf24 |
chromosome 20 open reading frame 24 |
|
affects expression |
ISO |
20 |
35,234,137 |
35,240,960 |
RGD:6480464 |
CTD |
| G |
C21orf67 |
chromosome 21 open reading frame 67 |
|
increases expression |
EXP |
21 |
46,353,199 |
46,359,828 |
RGD:6480464 |
CTD |
| G |
C21orf91 |
chromosome 21 open reading frame 91 |
|
increases expression |
EXP |
21 |
19,161,284 |
19,191,703 |
RGD:6480464 |
CTD |
| G |
C2CD2 |
C2 calcium-dependent domain containing 2 |
|
affects expression |
ISO |
21 |
43,305,219 |
43,373,999 |
RGD:6480464 |
CTD |
| G |
C3orf18 |
chromosome 3 open reading frame 18 |
|
increases expression |
EXP |
3 |
50,595,456 |
50,608,458 |
RGD:6480464 |
CTD |
| G |
C3orf33 |
chromosome 3 open reading frame 33 |
|
increases expression |
EXP |
3 |
155,480,401 |
155,524,055 |
RGD:6480464 |
CTD |
| G |
C4BPA |
complement component 4 binding protein, alpha |
|
affects expression |
ISO |
1 |
207,277,607 |
207,318,317 |
RGD:6480464 |
CTD |
| G |
C6orf141 |
chromosome 6 open reading frame 141 |
|
increases expression |
EXP |
6 |
49,518,113 |
49,519,808 |
RGD:6480464 |
CTD |
| G |
C7 |
complement component 7 |
|
affects expression |
ISO |
5 |
40,909,599 |
40,983,041 |
RGD:6480464 |
CTD |
| G |
C7orf31 |
chromosome 7 open reading frame 31 |
|
increases expression |
EXP |
7 |
25,174,316 |
25,219,817 |
RGD:6480464 |
CTD |
| G |
C8B |
complement component 8, beta polypeptide |
|
affects expression |
ISO |
1 |
57,394,883 |
57,431,688 |
RGD:6480464 |
CTD |
| G |
CA2 |
carbonic anhydrase II |
|
affects expression |
ISO |
8 |
86,376,131 |
86,393,721 |
RGD:6480464 |
CTD |
| G |
CA3 |
carbonic anhydrase III, muscle specific |
|
affects expression |
ISO |
8 |
86,351,056 |
86,361,269 |
RGD:6480464 |
CTD |
| G |
CA3 |
carbonic anhydrase III, muscle specific |
|
increases expression |
ISO |
8 |
86,351,056 |
86,361,269 |
RGD:6480464 |
CTD |
| G |
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
decreases expression |
ISO |
12 |
2,162,416 |
2,807,115 |
RGD:6480464 |
CTD |
| G |
CADPS2 |
Ca++-dependent secretion activator 2 |
|
affects expression |
ISO |
7 |
121,958,478 |
122,526,813 |
RGD:6480464 |
CTD |
| G |
CAMK2A |
calcium/calmodulin-dependent protein kinase II alpha |
|
increases expression |
EXP |
5 |
149,599,054 |
149,669,403 |
RGD:6480464 |
CTD |
| G |
CAPN11 |
calpain 11 |
|
increases expression |
EXP |
6 |
44,126,548 |
44,152,139 |
RGD:6480464 |
CTD |
| G |
CAPN3 |
calpain 3, (p94) |
|
increases expression |
EXP |
15 |
42,651,698 |
42,704,515 |
RGD:6480464 |
CTD |
| G |
CAPRIN1 |
cell cycle associated protein 1 |
|
affects expression |
ISO |
11 |
34,073,230 |
34,124,157 |
RGD:6480464 |
CTD |
| G |
CARD9 |
caspase recruitment domain family, member 9 |
|
increases expression |
EXP |
9 |
139,258,408 |
139,268,133 |
RGD:6480464 |
CTD |
| G |
CASKIN2 |
CASK interacting protein 2 |
|
increases expression |
EXP |
17 |
73,496,342 |
73,511,627 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
affects expression |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
decreases expression |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases expression |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAV3 |
caveolin 3 |
|
increases expression |
EXP |
3 |
8,775,486 |
8,788,451 |
RGD:6480464 |
CTD |
| G |
CBR1 |
carbonyl reductase 1 |
|
affects expression |
ISO |
21 |
37,442,285 |
37,445,462 |
RGD:6480464 |
CTD |
| G |
CCDC134 |
coiled-coil domain containing 134 |
|
increases expression |
EXP |
22 |
42,196,678 |
42,222,306 |
RGD:6480464 |
CTD |
| G |
CCDC135 |
coiled-coil domain containing 135 |
|
increases expression |
EXP |
16 |
57,728,713 |
57,765,367 |
RGD:6480464 |
CTD |
| G |
CCDC17 |
coiled-coil domain containing 17 |
|
increases expression |
EXP |
1 |
46,085,716 |
46,089,731 |
RGD:6480464 |
CTD |
| G |
CCDC9 |
coiled-coil domain containing 9 |
|
increases expression |
EXP |
19 |
47,759,731 |
47,775,210 |
RGD:6480464 |
CTD |
| G |
CCDC96 |
coiled-coil domain containing 96 |
|
increases expression |
EXP |
4 |
7,042,576 |
7,044,728 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCNT1 |
cyclin T1 |
|
increases expression |
EXP |
12 |
49,082,241 |
49,110,781 |
RGD:6480464 |
CTD |
| G |
CD320 |
CD320 molecule |
|
increases expression |
EXP |
19 |
8,367,011 |
8,373,240 |
RGD:6480464 |
CTD |
| G |
CDC25A |
cell division cycle 25A |
|
increases expression |
EXP |
3 |
48,198,668 |
48,229,801 |
RGD:6480464 |
CTD |
| G |
CLCN6 |
chloride channel, voltage-sensitive 6 |
|
increases expression |
EXP |
1 |
11,866,153 |
11,903,201 |
RGD:6480464 |
CTD |
| G |
CMBL |
carboxymethylenebutenolidase homolog (Pseudomonas) |
|
affects expression |
ISO |
5 |
10,277,707 |
10,308,168 |
RGD:6480464 |
CTD |
| G |
CMPK1 |
cytidine monophosphate (UMP-CMP) kinase 1, cytosolic |
|
affects expression |
ISO |
1 |
47,799,469 |
47,844,511 |
RGD:6480464 |
CTD |
| G |
CMTM6 |
CKLF-like MARVEL transmembrane domain containing 6 |
|
affects expression |
ISO |
3 |
32,522,804 |
32,544,403 |
RGD:6480464 |
CTD |
| G |
CMTM7 |
CKLF-like MARVEL transmembrane domain containing 7 |
|
increases expression |
EXP |
3 |
32,433,163 |
32,496,333 |
RGD:6480464 |
CTD |
| G |
CMYA5 |
cardiomyopathy associated 5 |
|
increases expression |
EXP |
5 |
78,985,659 |
79,096,049 |
RGD:6480464 |
CTD |
| G |
CNIH3 |
cornichon homolog 3 (Drosophila) |
|
increases expression |
EXP |
1 |
224,804,179 |
224,928,249 |
RGD:6480464 |
CTD |
| G |
CNNM2 |
cyclin M2 |
|
increases expression |
EXP |
10 |
104,678,075 |
104,838,344 |
RGD:6480464 |
CTD |
| G |
CNOT7 |
CCR4-NOT transcription complex, subunit 7 |
|
increases expression |
EXP |
8 |
17,086,740 |
17,104,387 |
RGD:6480464 |
CTD |
| G |
CNP |
2',3'-cyclic nucleotide 3' phosphodiesterase |
|
increases expression |
EXP |
17 |
40,118,759 |
40,129,754 |
RGD:6480464 |
CTD |
| G |
COL11A1 |
collagen, type XI, alpha 1 |
|
increases expression |
EXP |
1 |
103,342,023 |
103,574,052 |
RGD:6480464 |
CTD |
| G |
COL27A1 |
collagen, type XXVII, alpha 1 |
|
increases expression |
EXP |
9 |
116,918,231 |
117,072,975 |
RGD:6480464 |
CTD |
| G |
COL8A2 |
collagen, type VIII, alpha 2 |
|
increases expression |
EXP |
1 |
36,560,842 |
36,565,850 |
RGD:6480464 |
CTD |
| G |
COPG1 |
coatomer protein complex, subunit gamma 1 |
|
affects expression |
ISO |
3 |
128,968,453 |
128,996,616 |
RGD:6480464 |
CTD |
| G |
COPS4 |
COP9 signalosome subunit 4 |
|
affects expression |
ISO |
4 |
83,956,239 |
83,996,971 |
RGD:6480464 |
CTD |
| G |
COQ3 |
coenzyme Q3 homolog, methyltransferase (S. cerevisiae) |
|
affects expression |
ISO |
6 |
99,817,348 |
99,842,082 |
RGD:6480464 |
CTD |
| G |
CORO2A |
coronin, actin binding protein, 2A |
|
increases expression |
EXP |
9 |
100,883,257 |
100,954,956 |
RGD:6480464 |
CTD |
| G |
COX4I1 |
cytochrome c oxidase subunit IV isoform 1 |
|
affects expression |
ISO |
16 |
85,833,173 |
85,840,608 |
RGD:6480464 |
CTD |
| G |
CPLX2 |
complexin 2 |
|
increases expression |
EXP |
5 |
175,223,610 |
175,311,023 |
RGD:6480464 |
CTD |
| G |
CPN1 |
carboxypeptidase N, polypeptide 1 |
|
affects expression |
ISO |
10 |
101,802,065 |
101,841,642 |
RGD:6480464 |
CTD |
| G |
CPPED1 |
calcineurin-like phosphoesterase domain containing 1 |
|
affects expression |
ISO |
16 |
12,753,656 |
12,897,744 |
RGD:6480464 |
CTD |
| G |
CPQ |
carboxypeptidase Q |
|
affects expression |
ISO |
8 |
97,657,499 |
98,155,722 |
RGD:6480464 |
CTD |
| G |
CRB3 |
crumbs homolog 3 (Drosophila) |
|
increases expression |
EXP |
19 |
6,464,260 |
6,467,232 |
RGD:6480464 |
CTD |
| G |
CREM |
cAMP responsive element modulator |
|
affects expression |
ISO |
10 |
35,415,769 |
35,501,886 |
RGD:6480464 |
CTD |
| G |
CRP |
C-reactive protein, pentraxin-related |
|
multiple interactions |
EXP |
1 |
159,682,079 |
159,684,379 |
RGD:6480464 |
CTD |
| G |
CRTC1 |
CREB regulated transcription coactivator 1 |
|
decreases expression |
ISO |
19 |
18,794,425 |
18,893,143 |
RGD:6480464 |
CTD |
| G |
CRTC1 |
CREB regulated transcription coactivator 1 |
|
decreases expression |
ISO |
19 |
18,794,425 |
18,893,143 |
RGD:6480464 |
CTD |
| G |
CSNK2B |
casein kinase 2, beta polypeptide |
|
affects expression |
ISO |
6 |
31,633,657 |
31,637,843 |
RGD:6480464 |
CTD |
| G |
CSRP1 |
cysteine and glycine-rich protein 1 |
|
affects expression |
ISO |
1 |
201,452,658 |
201,476,387 |
RGD:6480464 |
CTD |
| G |
CST6 |
cystatin E/M |
|
increases expression |
EXP |
11 |
65,779,462 |
65,780,976 |
RGD:6480464 |
CTD |
| G |
CST7 |
cystatin F (leukocystatin) |
|
increases expression |
EXP |
20 |
24,929,866 |
24,940,564 |
RGD:6480464 |
CTD |
| G |
CTC1 |
CTS telomere maintenance complex component 1 |
|
increases expression |
EXP |
17 |
8,128,139 |
8,151,413 |
RGD:6480464 |
CTD |
| G |
CTLA4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
increases expression |
EXP |
2 |
204,732,511 |
204,738,683 |
RGD:6480464 |
CTD |
| G |
CTNNA1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
|
affects expression |
ISO |
5 |
138,089,107 |
138,270,723 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
increases expression |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
decreases activity |
EXP |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP26A1 |
cytochrome P450, family 26, subfamily A, polypeptide 1 |
|
increases expression |
EXP |
10 |
94,833,232 |
94,837,641 |
RGD:6480464 |
CTD |
| G |
CYP2B6 |
cytochrome P450, family 2, subfamily B, polypeptide 6 |
|
affects expression |
ISO |
19 |
41,497,204 |
41,524,301 |
RGD:6480464 |
CTD |
| G |
CYP2C8 |
cytochrome P450, family 2, subfamily C, polypeptide 8 |
|
decreases activity |
EXP |
10 |
96,796,529 |
96,829,254 |
RGD:6480464 |
CTD |
| G |
CYP2C8 |
cytochrome P450, family 2, subfamily C, polypeptide 8 |
|
increases metabolic processing |
EXP |
10 |
96,796,529 |
96,829,254 |
RGD:6480464 |
CTD |
| G |
CYP2C8 |
cytochrome P450, family 2, subfamily C, polypeptide 8 |
|
multiple interactions |
EXP |
10 |
96,796,529 |
96,829,254 |
RGD:6480464 |
CTD |
| G |
CYP2C9 |
cytochrome P450, family 2, subfamily C, polypeptide 9 |
|
multiple interactions |
EXP |
10 |
96,698,415 |
96,749,148 |
RGD:6480464 |
CTD |
| G |
CYP2C9 |
cytochrome P450, family 2, subfamily C, polypeptide 9 |
|
decreases activity |
EXP |
10 |
96,698,415 |
96,749,148 |
RGD:6480464 |
CTD |
| G |
CYP2C9 |
cytochrome P450, family 2, subfamily C, polypeptide 9 |
|
multiple interactions |
EXP |
10 |
96,698,415 |
96,749,148 |
RGD:6480464 |
CTD |
| G |
CYP2D6 |
cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
affects expression |
ISO |
22 |
42,522,501 |
42,526,883 |
RGD:6480464 |
CTD |
| G |
CYP2D6 |
cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
decreases activity |
EXP |
22 |
42,522,501 |
42,526,883 |
RGD:6480464 |
CTD |
| G |
CYP2D6 |
cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
increases expression |
EXP |
22 |
42,522,501 |
42,526,883 |
RGD:6480464 |
CTD |
| G |
CYP2D6 |
cytochrome P450, family 2, subfamily D, polypeptide 6 |
|
multiple interactions |
EXP |
22 |
42,522,501 |
42,526,883 |
RGD:6480464 |
CTD |
| G |
CYP2F1 |
cytochrome P450, family 2, subfamily F, polypeptide 1 |
|
affects expression |
ISO |
19 |
41,620,353 |
41,634,281 |
RGD:6480464 |
CTD |
| G |
CYP2J2 |
cytochrome P450, family 2, subfamily J, polypeptide 2 |
|
increases expression |
EXP |
1 |
60,358,980 |
60,392,423 |
RGD:6480464 |
CTD |
| G |
CYP2J2 |
cytochrome P450, family 2, subfamily J, polypeptide 2 |
|
affects expression |
ISO |
1 |
60,358,980 |
60,392,423 |
RGD:6480464 |
CTD |
| G |
CYP2R1 |
cytochrome P450, family 2, subfamily R, polypeptide 1 |
|
increases expression |
EXP |
11 |
14,899,555 |
14,913,751 |
RGD:6480464 |
CTD |
| G |
CYP3A |
cytochrome P450, subfamily IIA (niphedipine oxidase) |
|
decreases ethylation |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
CYP3A |
cytochrome P450, subfamily IIA (niphedipine oxidase) |
|
increases metabolic processing |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
CYP3A |
cytochrome P450, subfamily IIA (niphedipine oxidase) |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
increases expression |
ISO |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
multiple interactions |
EXP |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
decreases activity |
EXP |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
increases metabolic processing |
EXP |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
decreases activity |
EXP |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
decreases ethylation |
EXP |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
increases metabolic processing |
EXP |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
increases response to substance |
EXP |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
increases expression |
ISO |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A4 |
cytochrome P450, family 3, subfamily A, polypeptide 4 |
|
multiple interactions |
EXP |
7 |
99,354,583 |
99,381,811 |
RGD:6480464 |
CTD |
| G |
CYP3A5 |
cytochrome P450, family 3, subfamily A, polypeptide 5 |
|
affects expression |
ISO |
7 |
99,245,813 |
99,277,621 |
RGD:6480464 |
CTD |
| G |
CYP4A11 |
cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
increases expression |
ISO |
1 |
47,394,846 |
47,407,156 |
RGD:6480464 |
CTD |
| G |
CYP4A11 |
cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
increases expression |
ISO |
1 |
47,394,846 |
47,407,156 |
RGD:6480464 |
CTD |
| G |
CYP4A22 |
cytochrome P450, family 4, subfamily A, polypeptide 22 |
|
affects expression |
ISO |
1 |
47,603,107 |
47,614,526 |
RGD:6480464 |
CTD |
| G |
CYP4F2 |
cytochrome P450, family 4, subfamily F, polypeptide 2 |
|
affects expression |
ISO |
19 |
15,988,834 |
16,008,884 |
RGD:6480464 |
CTD |
| G |
CYP4F2 |
cytochrome P450, family 4, subfamily F, polypeptide 2 |
|
affects expression |
ISO |
19 |
15,988,834 |
16,008,884 |
RGD:6480464 |
CTD |
| G |
CYP4F3 |
cytochrome P450, family 4, subfamily F, polypeptide 3 |
|
affects expression |
ISO |
19 |
15,751,707 |
15,771,570 |
RGD:6480464 |
CTD |
| G |
CYP7A1 |
cytochrome P450, family 7, subfamily A, polypeptide 1 |
|
decreases expression |
ISO |
8 |
59,402,737 |
59,412,720 |
RGD:6480464 |
CTD |
| G |
DAK |
dihydroxyacetone kinase 2 homolog (S. cerevisiae) |
|
affects expression |
ISO |
11 |
61,100,654 |
61,116,231 |
RGD:6480464 |
CTD |
| G |
DAPK2 |
death-associated protein kinase 2 |
|
increases expression |
EXP |
15 |
64,199,235 |
64,338,521 |
RGD:6480464 |
CTD |
| G |
DBI |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
affects expression |
ISO |
2 |
120,124,504 |
120,130,122 |
RGD:6480464 |
CTD |
| G |
DBN1 |
drebrin 1 |
|
increases expression |
EXP |
5 |
176,883,614 |
176,900,694 |
RGD:6480464 |
CTD |
| G |
DBNDD1 |
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
|
increases expression |
EXP |
16 |
90,071,279 |
90,085,937 |
RGD:6480464 |
CTD |
| G |
DCAF11 |
DDB1 and CUL4 associated factor 11 |
|
affects expression |
ISO |
14 |
24,583,906 |
24,594,451 |
RGD:6480464 |
CTD |
| G |
DCAF8 |
DDB1 and CUL4 associated factor 8 |
|
affects expression |
ISO |
1 |
160,185,505 |
160,232,350 |
RGD:6480464 |
CTD |
| G |
DCST2 |
DC-STAMP domain containing 2 |
|
increases expression |
EXP |
1 |
154,991,003 |
155,006,257 |
RGD:6480464 |
CTD |
| G |
DCTN1 |
dynactin 1 |
|
increases expression |
EXP |
2 |
74,588,281 |
74,619,214 |
RGD:6480464 |
CTD |
| G |
DCXR |
dicarbonyl/L-xylulose reductase |
|
affects expression |
ISO |
17 |
79,993,757 |
79,995,573 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
increases expression |
EXP |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
increases expression |
EXP |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
multiple interactions |
EXP |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
EXP |
10 |
74,033,677 |
74,035,797 |
RGD:6480464 |
CTD |
| G |
DDX17 |
DEAD (Asp-Glu-Ala-Asp) box helicase 17 |
|
increases expression |
EXP |
22 |
38,879,443 |
38,902,345 |
RGD:6480464 |
CTD |
| G |
DDX31 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31 |
|
increases expression |
EXP |
9 |
135,469,676 |
135,545,788 |
RGD:6480464 |
CTD |
| G |
DDX39A |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A |
|
increases expression |
EXP |
19 |
14,519,610 |
14,530,195 |
RGD:6480464 |
CTD |
| G |
DDX49 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 49 |
|
increases expression |
EXP |
19 |
19,030,484 |
19,039,442 |
RGD:6480464 |
CTD |
| G |
DECR1 |
2,4-dienoyl CoA reductase 1, mitochondrial |
|
affects expression |
ISO |
8 |
91,013,580 |
91,064,227 |
RGD:6480464 |
CTD |
| G |
DEDD |
death effector domain containing |
|
increases expression |
EXP |
1 |
161,090,767 |
161,102,478 |
RGD:6480464 |
CTD |
| G |
DEPTOR |
DEP domain containing MTOR-interacting protein |
|
increases expression |
EXP |
8 |
120,885,900 |
121,063,157 |
RGD:6480464 |
CTD |
| G |
DEXI |
Dexi homolog (mouse) |
|
affects expression |
ISO |
16 |
11,022,748 |
11,036,257 |
RGD:6480464 |
CTD |
| G |
DEXI |
Dexi homolog (mouse) |
|
affects expression |
ISO |
16 |
11,022,748 |
11,036,257 |
RGD:6480464 |
CTD |
| G |
DGAT1 |
diacylglycerol O-acyltransferase 1 |
|
affects expression |
ISO |
8 |
145,538,247 |
145,550,567 |
RGD:6480464 |
CTD |
| G |
DHCR24 |
24-dehydrocholesterol reductase |
|
affects expression |
ISO |
1 |
55,315,300 |
55,352,921 |
RGD:6480464 |
CTD |
| G |
DHRS2 |
dehydrogenase/reductase (SDR family) member 2 |
|
increases expression |
EXP |
14 |
24,105,573 |
24,114,848 |
RGD:6480464 |
CTD |
| G |
DHRS4 |
dehydrogenase/reductase (SDR family) member 4 |
|
affects expression |
ISO |
14 |
24,422,965 |
24,438,488 |
RGD:6480464 |
CTD |
| G |
DHRS7B |
dehydrogenase/reductase (SDR family) member 7B |
|
affects expression |
ISO |
17 |
21,030,241 |
21,095,285 |
RGD:6480464 |
CTD |
| G |
DHX16 |
DEAH (Asp-Glu-Ala-His) box polypeptide 16 |
|
affects expression |
ISO |
6 |
30,620,896 |
30,640,830 |
RGD:6480464 |
CTD |
| G |
DHX57 |
DEAH (Asp-Glu-Ala-Asp/His) box polypeptide 57 |
|
increases expression |
EXP |
2 |
39,024,871 |
39,103,021 |
RGD:6480464 |
CTD |
| G |
DIO1 |
deiodinase, iodothyronine, type I |
|
decreases activity |
ISO |
1 |
54,359,861 |
54,376,759 |
RGD:6480464 |
CTD |
| G |
DIO1 |
deiodinase, iodothyronine, type I |
|
decreases activity |
EXP |
1 |
54,359,861 |
54,376,759 |
RGD:6480464 |
CTD |
| G |
DLG4 |
discs, large homolog 4 (Drosophila) |
|
increases expression |
EXP |
17 |
7,093,209 |
7,123,369 |
RGD:6480464 |
CTD |
| G |
DLK2 |
delta-like 2 homolog (Drosophila) |
|
increases expression |
EXP |
6 |
43,418,090 |
43,423,786 |
RGD:6480464 |
CTD |
| G |
DNAAF3 |
dynein, axonemal, assembly factor 3 |
|
increases expression |
EXP |
19 |
55,670,029 |
55,678,090 |
RGD:6480464 |
CTD |
| G |
DNAH7 |
dynein, axonemal, heavy chain 7 |
|
increases expression |
EXP |
2 |
196,602,427 |
196,933,536 |
RGD:6480464 |
CTD |
| G |
DNAJB12 |
DnaJ (Hsp40) homolog, subfamily B, member 12 |
|
increases expression |
EXP |
10 |
74,092,588 |
74,114,907 |
RGD:6480464 |
CTD |
| G |
DNAJB7 |
DnaJ (Hsp40) homolog, subfamily B, member 7 |
|
increases expression |
EXP |
22 |
41,255,553 |
41,258,130 |
RGD:6480464 |
CTD |
| G |
DNAJB9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
increases expression |
EXP |
7 |
108,210,189 |
108,215,294 |
RGD:6480464 |
CTD |
| G |
DNAJC3 |
DnaJ (Hsp40) homolog, subfamily C, member 3 |
|
affects expression |
ISO |
13 |
96,329,393 |
96,447,243 |
RGD:6480464 |
CTD |
| G |
DNASE1 |
deoxyribonuclease I |
|
increases expression |
EXP |
16 |
3,702,940 |
3,708,096 |
RGD:6480464 |
CTD |
| G |
DOCK5 |
dedicator of cytokinesis 5 |
|
increases expression |
EXP |
8 |
25,042,287 |
25,270,619 |
RGD:6480464 |
CTD |
| G |
DPM2 |
dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit |
|
increases expression |
EXP |
9 |
130,697,374 |
130,700,763 |
RGD:6480464 |
CTD |
| G |
DPP4 |
dipeptidyl-peptidase 4 |
|
affects expression |
ISO |
2 |
162,848,755 |
162,931,052 |
RGD:6480464 |
CTD |
| G |
DPYD |
dihydropyrimidine dehydrogenase |
|
affects expression |
ISO |
1 |
97,543,299 |
98,386,615 |
RGD:6480464 |
CTD |
| G |
DUSP1 |
dual specificity phosphatase 1 |
|
increases expression |
EXP |
5 |
172,195,093 |
172,198,203 |
RGD:6480464 |
CTD |
| G |
DUSP10 |
dual specificity phosphatase 10 |
|
increases expression |
EXP |
1 |
221,874,764 |
221,915,516 |
RGD:6480464 |
CTD |
| G |
DUT |
deoxyuridine triphosphatase |
|
increases expression |
EXP |
15 |
48,623,621 |
48,635,570 |
RGD:6480464 |
CTD |
| G |
EAF2 |
ELL associated factor 2 |
|
increases expression |
EXP |
3 |
121,554,034 |
121,605,373 |
RGD:6480464 |
CTD |
| G |
EARS2 |
glutamyl-tRNA synthetase 2, mitochondrial |
|
affects expression |
ISO |
16 |
23,533,334 |
23,568,696 |
RGD:6480464 |
CTD |
| G |
EFCC1 |
EF-hand and coiled-coil domain containing 1 |
|
increases expression |
EXP |
3 |
128,720,472 |
128,759,585 |
RGD:6480464 |
CTD |
| G |
ENC1 |
ectodermal-neural cortex 1 (with BTB domain) |
|
affects expression |
ISO |
5 |
73,923,231 |
73,937,249 |
RGD:6480464 |
CTD |
| G |
ENPEP |
glutamyl aminopeptidase (aminopeptidase A) |
|
affects expression |
ISO |
4 |
111,397,229 |
111,484,493 |
RGD:6480464 |
CTD |
| G |
ENPP7 |
ectonucleotide pyrophosphatase/phosphodiesterase 7 |
|
increases expression |
EXP |
17 |
77,704,882 |
77,716,021 |
RGD:6480464 |
CTD |
| G |
EPC1 |
enhancer of polycomb homolog 1 (Drosophila) |
|
increases expression |
EXP |
10 |
32,557,859 |
32,636,113 |
RGD:6480464 |
CTD |
| G |
EPC2 |
enhancer of polycomb homolog 2 (Drosophila) |
|
increases expression |
EXP |
2 |
149,402,560 |
149,545,136 |
RGD:6480464 |
CTD |
| G |
EPCAM |
epithelial cell adhesion molecule |
|
affects expression |
ISO |
2 |
47,596,287 |
47,614,167 |
RGD:6480464 |
CTD |
| G |
EPHX1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
affects expression |
ISO |
1 |
225,997,797 |
226,033,264 |
RGD:6480464 |
CTD |
| G |
ERI2 |
ERI1 exoribonuclease family member 2 |
|
increases expression |
EXP |
16 |
20,791,515 |
20,817,795 |
RGD:6480464 |
CTD |
| G |
ERMN |
ermin, ERM-like protein |
|
increases expression |
EXP |
2 |
158,175,125 |
158,184,146 |
RGD:6480464 |
CTD |
| G |
ERP29 |
endoplasmic reticulum protein 29 |
|
affects expression |
ISO |
12 |
112,451,152 |
112,461,024 |
RGD:6480464 |
CTD |
| G |
ESD |
esterase D |
|
affects expression |
ISO |
13 |
47,345,391 |
47,371,367 |
RGD:6480464 |
CTD |
| G |
ETFB |
electron-transfer-flavoprotein, beta polypeptide |
|
affects expression |
ISO |
19 |
51,848,409 |
51,869,672 |
RGD:6480464 |
CTD |
| G |
ETV7 |
ets variant 7 |
|
increases expression |
EXP |
6 |
36,321,998 |
36,355,577 |
RGD:6480464 |
CTD |
| G |
EXO1 |
exonuclease 1 |
|
increases expression |
EXP |
1 |
242,011,493 |
242,053,241 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II (thrombin) |
|
multiple interactions |
EXP |
11 |
46,740,743 |
46,761,056 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
multiple interactions |
EXP |
1 |
94,994,732 |
95,007,413 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
decreases activity |
ISO |
1 |
94,994,732 |
95,007,413 |
RGD:6480464 |
CTD |
| G |
FAAH |
fatty acid amide hydrolase |
|
affects expression |
ISO |
1 |
46,859,939 |
46,879,520 |
RGD:6480464 |
CTD |
| G |
FABP1 |
fatty acid binding protein 1, liver |
|
increases expression |
EXP |
2 |
88,422,501 |
88,427,650 |
RGD:6480464 |
CTD |
| G |
FADS1 |
fatty acid desaturase 1 |
|
increases expression |
ISO |
11 |
61,567,097 |
61,584,529 |
RGD:6480464 |
CTD |
| G |
FADS2 |
fatty acid desaturase 2 |
|
multiple interactions |
EXP |
11 |
61,595,713 |
61,634,825 |
RGD:6480464 |
CTD |
| G |
FADS2 |
fatty acid desaturase 2 |
|
increases expression |
EXP |
11 |
61,595,713 |
61,634,825 |
RGD:6480464 |
CTD |
| G |
FADS2 |
fatty acid desaturase 2 |
|
affects expression |
ISO |
11 |
61,595,713 |
61,634,825 |
RGD:6480464 |
CTD |
| G |
FAM129A |
family with sequence similarity 129, member A |
|
increases expression |
EXP |
1 |
184,760,166 |
184,943,682 |
RGD:6480464 |
CTD |
| G |
FAM150A |
family with sequence similarity 150, member A |
|
increases expression |
EXP |
8 |
53,446,597 |
53,478,021 |
RGD:6480464 |
CTD |
| G |
FAM153A |
family with sequence similarity 153, member A |
|
increases expression |
EXP |
5 |
177,150,365 |
177,207,505 |
RGD:6480464 |
CTD |
| G |
FAM212B |
family with sequence similarity 212, member B |
|
increases expression |
EXP |
1 |
112,264,686 |
112,298,419 |
RGD:6480464 |
CTD |
| G |
FAM81A |
family with sequence similarity 81, member A |
|
increases expression |
EXP |
15 |
59,730,372 |
59,815,751 |
RGD:6480464 |
CTD |
| G |
FAM89A |
family with sequence similarity 89, member A |
|
increases expression |
EXP |
1 |
231,154,704 |
231,175,995 |
RGD:6480464 |
CTD |
| G |
FANCA |
Fanconi anemia, complementation group A |
|
increases expression |
EXP |
16 |
89,803,959 |
89,883,065 |
RGD:6480464 |
CTD |
| G |
FARP2 |
FERM, RhoGEF and pleckstrin domain protein 2 |
|
increases expression |
EXP |
2 |
242,295,664 |
242,434,256 |
RGD:6480464 |
CTD |
| G |
FBP1 |
fructose-1,6-bisphosphatase 1 |
|
affects expression |
ISO |
9 |
97,365,415 |
97,402,531 |
RGD:6480464 |
CTD |
| G |
FBXO16 |
F-box protein 16 |
|
increases expression |
EXP |
8 |
28,285,925 |
28,347,835 |
RGD:6480464 |
CTD |
| G |
FBXO32 |
F-box protein 32 |
|
increases expression |
EXP |
8 |
124,510,127 |
124,553,493 |
RGD:6480464 |
CTD |
| G |
FCRL1 |
Fc receptor-like 1 |
|
increases expression |
EXP |
1 |
157,764,193 |
157,789,940 |
RGD:6480464 |
CTD |
| G |
FCRL2 |
Fc receptor-like 2 |
|
increases expression |
EXP |
1 |
157,715,523 |
157,746,922 |
RGD:6480464 |
CTD |
| G |
FCRL3 |
Fc receptor-like 3 |
|
increases expression |
EXP |
1 |
157,647,978 |
157,670,647 |
RGD:6480464 |
CTD |
| G |
FDFT1 |
farnesyl-diphosphate farnesyltransferase 1 |
|
affects expression |
ISO |
8 |
11,660,190 |
11,696,818 |
RGD:6480464 |
CTD |
| G |
FDPS |
farnesyl diphosphate synthase |
|
affects expression |
ISO |
1 |
155,278,539 |
155,290,457 |
RGD:6480464 |
CTD |
| G |
FDX1L |
ferredoxin 1-like |
|
affects expression |
ISO |
19 |
10,420,891 |
10,426,691 |
RGD:6480464 |
CTD |
| G |
FFAR3 |
free fatty acid receptor 3 |
|
increases expression |
EXP |
19 |
35,849,488 |
35,851,391 |
RGD:6480464 |
CTD |
| G |
FGD4 |
FYVE, RhoGEF and PH domain containing 4 |
|
increases expression |
EXP |
12 |
32,655,041 |
32,798,984 |
RGD:6480464 |
CTD |
| G |
FGD5 |
FYVE, RhoGEF and PH domain containing 5 |
|
increases expression |
EXP |
3 |
14,860,469 |
14,976,072 |
RGD:6480464 |
CTD |
| G |
FGFR1OP2 |
FGFR1 oncogene partner 2 |
|
increases expression |
EXP |
12 |
27,091,305 |
27,119,581 |
RGD:6480464 |
CTD |
| G |
FIBCD1 |
fibrinogen C domain containing 1 |
|
increases expression |
EXP |
9 |
133,777,825 |
133,814,455 |
RGD:6480464 |
CTD |
| G |
FKBP10 |
FK506 binding protein 10, 65 kDa |
|
increases expression |
EXP |
17 |
39,968,962 |
39,979,469 |
RGD:6480464 |
CTD |
| G |
FLCN |
folliculin |
|
increases expression |
EXP |
17 |
17,115,526 |
17,140,502 |
RGD:6480464 |
CTD |
| G |
FMO1 |
flavin containing monooxygenase 1 |
|
affects expression |
ISO |
1 |
171,217,663 |
171,255,113 |
RGD:6480464 |
CTD |
| G |
FNDC4 |
fibronectin type III domain containing 4 |
|
increases expression |
EXP |
2 |
27,714,750 |
27,718,126 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOSB |
FBJ murine osteosarcoma viral oncogene homolog B |
|
increases expression |
EXP |
19 |
45,971,253 |
45,978,437 |
RGD:6480464 |
CTD |
| G |
FOXA3 |
forkhead box A3 |
|
decreases expression |
ISO |
19 |
46,367,518 |
46,377,055 |
RGD:6480464 |
CTD |
| G |
FOXP3 |
forkhead box P3 |
|
increases expression |
EXP |
X |
49,106,897 |
49,121,288 |
RGD:6480464 |
CTD |
| G |
FRAS1 |
Fraser syndrome 1 |
|
increases expression |
EXP |
4 |
78,978,724 |
79,465,423 |
RGD:6480464 |
CTD |
| G |
FRMD3 |
FERM domain containing 3 |
|
increases expression |
EXP |
9 |
85,857,905 |
86,153,348 |
RGD:6480464 |
CTD |
| G |
FRMD5 |
FERM domain containing 5 |
|
increases expression |
EXP |
15 |
44,165,730 |
44,487,429 |
RGD:6480464 |
CTD |
| G |
FUNDC2 |
FUN14 domain containing 2 |
|
increases expression |
EXP |
X |
154,255,064 |
154,285,191 |
RGD:6480464 |
CTD |
| G |
FUT4 |
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) |
|
decreases expression |
ISO |
11 |
94,277,017 |
94,283,064 |
RGD:6480464 |
CTD |
| G |
FUZ |
fuzzy planar cell polarity protein |
|
increases expression |
EXP |
19 |
50,310,123 |
50,316,567 |
RGD:6480464 |
CTD |
| G |
FXYD1 |
FXYD domain containing ion transport regulator 1 |
|
increases expression |
EXP |
19 |
35,629,732 |
35,633,954 |
RGD:6480464 |
CTD |
| G |
G6PD |
glucose-6-phosphate dehydrogenase |
|
increases expression |
ISO |
X |
153,759,606 |
153,775,787 |
RGD:6480464 |
CTD |
| G |
G6PD |
glucose-6-phosphate dehydrogenase |
|
increases expression |
EXP |
X |
153,759,606 |
153,775,787 |
RGD:6480464 |
CTD |
| G |
GADD45A |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
EXP |
1 |
68,150,860 |
68,154,021 |
RGD:6480464 |
CTD |
| G |
GADD45G |
growth arrest and DNA-damage-inducible, gamma |
|
increases expression |
EXP |
9 |
92,219,927 |
92,221,470 |
RGD:6480464 |
CTD |
| G |
GAL3ST3 |
galactose-3-O-sulfotransferase 3 |
|
increases expression |
EXP |
11 |
65,808,236 |
65,816,651 |
RGD:6480464 |
CTD |
| G |
GAMT |
guanidinoacetate N-methyltransferase |
|
affects expression |
ISO |
19 |
1,397,025 |
1,401,569 |
RGD:6480464 |
CTD |
| G |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
|
affects expression |
ISO |
12 |
6,643,585 |
6,647,537 |
RGD:6480464 |
CTD |
| G |
GATA2 |
GATA binding protein 2 |
|
decreases expression |
ISO |
3 |
128,198,265 |
128,212,030 |
RGD:6480464 |
CTD |
| G |
GBE1 |
glucan (1,4-alpha-), branching enzyme 1 |
|
affects expression |
ISO |
3 |
81,538,850 |
81,810,950 |
RGD:6480464 |
CTD |
| G |
GBP2 |
guanylate binding protein 2, interferon-inducible |
|
increases expression |
EXP |
1 |
89,573,310 |
89,591,799 |
RGD:6480464 |
CTD |
| G |
GCHFR |
GTP cyclohydrolase I feedback regulator |
|
affects expression |
ISO |
15 |
41,056,285 |
41,059,911 |
RGD:6480464 |
CTD |
| G |
GCKR |
glucokinase (hexokinase 4) regulator |
|
affects expression |
ISO |
2 |
27,719,706 |
27,746,551 |
RGD:6480464 |
CTD |
| G |
GDF15 |
growth differentiation factor 15 |
|
increases expression |
EXP |
19 |
18,496,968 |
18,499,986 |
RGD:6480464 |
CTD |
| G |
GDF5 |
growth differentiation factor 5 |
|
increases expression |
EXP |
20 |
34,021,149 |
34,026,027 |
RGD:6480464 |
CTD |
| G |
GDPD3 |
glycerophosphodiester phosphodiesterase domain containing 3 |
|
increases expression |
EXP |
16 |
30,116,131 |
30,124,878 |
RGD:6480464 |
CTD |
| G |
GEM |
GTP binding protein overexpressed in skeletal muscle |
|
increases expression |
EXP |
8 |
95,261,481 |
95,274,547 |
RGD:6480464 |
CTD |
| G |
GFOD1 |
glucose-fructose oxidoreductase domain containing 1 |
|
increases expression |
EXP |
6 |
13,363,587 |
13,487,869 |
RGD:6480464 |
CTD |
| G |
GGH |
gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) |
|
affects expression |
ISO |
8 |
63,927,638 |
63,951,610 |
RGD:6480464 |
CTD |
| G |
GH1 |
growth hormone 1 |
|
multiple interactions |
ISO |
17 |
61,994,563 |
61,996,198 |
RGD:6480464 |
CTD |
| G |
GINS1 |
GINS complex subunit 1 (Psf1 homolog) |
|
increases expression |
EXP |
20 |
25,388,323 |
25,429,191 |
RGD:6480464 |
CTD |
| G |
GJA1 |
gap junction protein, alpha 1, 43kDa |
|
decreases expression |
ISO |
6 |
121,756,745 |
121,770,873 |
RGD:6480464 |
CTD |
| G |
GJA5 |
gap junction protein, alpha 5, 40kDa |
|
increases expression |
EXP |
1 |
147,228,332 |
147,245,484 |
RGD:6480464 |
CTD |
| G |
GJB1 |
gap junction protein, beta 1, 32kDa |
|
affects expression |
ISO |
X |
70,435,062 |
70,445,065 |
RGD:6480464 |
CTD |
| G |
GJD3 |
gap junction protein, delta 3, 31.9kDa |
|
increases expression |
EXP |
17 |
38,516,904 |
38,520,945 |
RGD:6480464 |
CTD |
| G |
GK5 |
glycerol kinase 5 (putative) |
|
increases expression |
EXP |
3 |
141,876,369 |
141,944,449 |
RGD:6480464 |
CTD |
| G |
GKAP1 |
G kinase anchoring protein 1 |
|
increases expression |
EXP |
9 |
86,354,336 |
86,432,752 |
RGD:6480464 |
CTD |
| G |
GLS2 |
glutaminase 2 (liver, mitochondrial) |
|
affects expression |
ISO |
12 |
56,864,736 |
56,882,181 |
RGD:6480464 |
CTD |
| G |
GLUD1 |
glutamate dehydrogenase 1 |
|
increases expression |
ISO |
10 |
88,809,959 |
88,854,776 |
RGD:6480464 |
CTD |
| G |
GNAS |
GNAS complex locus |
|
increases expression |
EXP |
20 |
57,414,795 |
57,486,250 |
RGD:6480464 |
CTD |
| G |
GNL1 |
guanine nucleotide binding protein-like 1 |
|
decreases expression |
ISO |
6 |
30,509,154 |
30,525,371 |
RGD:6480464 |
CTD |
| G |
GON4L |
gon-4-like (C. elegans) |
|
increases expression |
EXP |
1 |
155,719,510 |
155,826,972 |
RGD:6480464 |
CTD |
| G |
GOT2 |
glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) |
|
affects expression |
ISO |
16 |
58,741,035 |
58,768,246 |
RGD:6480464 |
CTD |
| G |
GPAM |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
increases expression |
ISO |
10 |
113,909,622 |
113,943,537 |
RGD:6480464 |
CTD |
| G |
GPLD1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
affects expression |
ISO |
6 |
24,426,060 |
24,489,850 |
RGD:6480464 |
CTD |
| G |
GPR133 |
G protein-coupled receptor 133 |
|
increases expression |
EXP |
12 |
131,438,452 |
131,626,010 |
RGD:6480464 |
CTD |
| G |
GPRC5C |
G protein-coupled receptor, family C, group 5, member C |
|
increases expression |
EXP |
17 |
72,427,667 |
72,443,568 |
RGD:6480464 |
CTD |
| G |
GPT |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases expression |
EXP |
8 |
145,729,465 |
145,732,555 |
RGD:6480464 |
CTD |
| G |
GPX1 |
glutathione peroxidase 1 |
|
affects expression |
ISO |
3 |
49,394,609 |
49,395,791 |
RGD:6480464 |
CTD |
| G |
GPX4 |
glutathione peroxidase 4 |
|
affects expression |
ISO |
19 |
1,103,936 |
1,106,787 |
RGD:6480464 |
CTD |
| G |
GRB14 |
growth factor receptor-bound protein 14 |
|
affects expression |
ISO |
2 |
165,349,323 |
165,478,360 |
RGD:6480464 |
CTD |
| G |
GRINA |
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
|
affects expression |
ISO |
8 |
145,064,226 |
145,067,583 |
RGD:6480464 |
CTD |
| G |
GRM2 |
glutamate receptor, metabotropic 2 |
|
increases expression |
EXP |
3 |
51,741,081 |
51,752,629 |
RGD:6480464 |
CTD |
| G |
GRPEL1 |
GrpE-like 1, mitochondrial (E. coli) |
|
affects expression |
ISO |
4 |
7,061,780 |
7,069,800 |
RGD:6480464 |
CTD |
| G |
GSN |
gelsolin |
|
increases expression |
ISO |
9 |
124,030,380 |
124,095,120 |
RGD:6480464 |
CTD |
| G |
GSTO2 |
glutathione S-transferase omega 2 |
|
increases expression |
EXP |
10 |
106,028,631 |
106,059,176 |
RGD:6480464 |
CTD |
| G |
GSTT1 |
glutathione S-transferase theta 1 |
|
affects expression |
ISO |
22 |
24,376,139 |
24,384,284 |
RGD:6480464 |
CTD |
| G |
GSTZ1 |
glutathione S-transferase zeta 1 |
|
increases expression |
EXP |
14 |
77,787,230 |
77,797,940 |
RGD:6480464 |
CTD |
| G |
GTF2H5 |
general transcription factor IIH, polypeptide 5 |
|
affects expression |
ISO |
6 |
158,589,379 |
158,620,376 |
RGD:6480464 |
CTD |
| G |
GULOP |
gulonolactone (L-) oxidase, pseudogene |
|
affects expression |
ISO |
8 |
27,435,128 |
27,446,590 |
RGD:6480464 |
CTD |
| G |
GZMA |
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
|
affects expression |
ISO |
5 |
54,398,474 |
54,406,080 |
RGD:6480464 |
CTD |
| G |
HLA-E |
major histocompatibility complex, class I, E |
|
affects expression |
ISO |
6 |
30,457,183 |
30,461,982 |
RGD:6480464 |
CTD |
| G |
HPRT1 |
hypoxanthine phosphoribosyltransferase 1 |
|
affects expression |
ISO |
X |
133,594,175 |
133,634,698 |
RGD:6480464 |
CTD |
| G |
HPS5 |
Hermansky-Pudlak syndrome 5 |
|
affects expression |
ISO |
11 |
18,300,217 |
18,343,721 |
RGD:6480464 |
CTD |
| G |
HRSP12 |
heat-responsive protein 12 |
|
affects expression |
ISO |
8 |
99,114,567 |
99,129,418 |
RGD:6480464 |
CTD |
| G |
HSD17B4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
|
affects expression |
ISO |
5 |
118,788,138 |
118,878,030 |
RGD:6480464 |
CTD |
| G |
HSDL2 |
hydroxysteroid dehydrogenase like 2 |
|
affects expression |
ISO |
9 |
115,142,189 |
115,234,685 |
RGD:6480464 |
CTD |
| G |
HSPD1 |
heat shock 60kDa protein 1 (chaperonin) |
|
increases expression |
ISO |
2 |
198,351,308 |
198,364,998 |
RGD:6480464 |
CTD |
| G |
HTRA1 |
HtrA serine peptidase 1 |
|
affects expression |
ISO |
10 |
124,221,041 |
124,274,424 |
RGD:6480464 |
CTD |
| G |
HUS1 |
HUS1 checkpoint homolog (S. pombe) |
|
increases expression |
EXP |
7 |
48,002,885 |
48,019,222 |
RGD:6480464 |
CTD |
| G |
ICAM1 |
intercellular adhesion molecule 1 |
|
increases expression |
EXP |
19 |
10,381,517 |
10,397,291 |
RGD:6480464 |
CTD |
| G |
IGF1 |
insulin-like growth factor 1 (somatomedin C) |
|
affects expression |
ISO |
12 |
102,789,645 |
102,874,378 |
RGD:6480464 |
CTD |
| G |
IGFALS |
insulin-like growth factor binding protein, acid labile subunit |
|
increases expression |
EXP |
16 |
1,840,414 |
1,844,909 |
RGD:6480464 |
CTD |
| G |
IGFALS |
insulin-like growth factor binding protein, acid labile subunit |
|
affects expression |
ISO |
16 |
1,840,414 |
1,844,909 |
RGD:6480464 |
CTD |
| G |
IGFBP2 |
insulin-like growth factor binding protein 2, 36kDa |
|
affects expression |
ISO |
2 |
217,498,127 |
217,529,159 |
RGD:6480464 |
CTD |
| G |
IGSF8 |
immunoglobulin superfamily, member 8 |
|
increases expression |
EXP |
1 |
160,061,129 |
160,068,618 |
RGD:6480464 |
CTD |
| G |
IKBKAP |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein |
|
increases expression |
EXP |
9 |
111,629,800 |
111,696,608 |
RGD:6480464 |
CTD |
| G |
IL10RA |
interleukin 10 receptor, alpha |
|
increases expression |
EXP |
11 |
117,857,106 |
117,872,198 |
RGD:6480464 |
CTD |
| G |
IL1A |
interleukin 1, alpha |
|
multiple interactions |
EXP |
2 |
113,531,492 |
113,542,971 |
RGD:6480464 |
CTD |
| G |
IL1A |
interleukin 1, alpha |
|
increases expression |
EXP |
2 |
113,531,492 |
113,542,971 |
RGD:6480464 |
CTD |
| G |
IL33 |
interleukin 33 |
|
affects expression |
ISO |
9 |
6,215,786 |
6,257,983 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases expression |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
increases secretion |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IMPA1 |
inositol(myo)-1(or 4)-monophosphatase 1 |
|
affects expression |
ISO |
8 |
82,569,151 |
82,598,589 |
RGD:6480464 |
CTD |
| G |
INHBE |
inhibin, beta E |
|
increases expression |
EXP |
12 |
57,849,096 |
57,851,791 |
RGD:6480464 |
CTD |
| G |
INHBE |
inhibin, beta E |
|
affects expression |
ISO |
12 |
57,849,096 |
57,851,791 |
RGD:6480464 |
CTD |
| G |
IPPK |
inositol 1,3,4,5,6-pentakisphosphate 2-kinase |
|
increases expression |
EXP |
9 |
95,375,466 |
95,432,547 |
RGD:6480464 |
CTD |
| G |
IRAK2 |
interleukin-1 receptor-associated kinase 2 |
|
increases expression |
EXP |
3 |
10,206,563 |
10,285,427 |
RGD:6480464 |
CTD |
| G |
IRF1 |
interferon regulatory factor 1 |
|
increases expression |
EXP |
5 |
131,817,301 |
131,826,465 |
RGD:6480464 |
CTD |
| G |
ISX |
intestine-specific homeobox |
|
increases expression |
EXP |
22 |
35,462,130 |
35,483,380 |
RGD:6480464 |
CTD |
| G |
ISYNA1 |
inositol-3-phosphate synthase 1 |
|
affects expression |
ISO |
19 |
18,545,198 |
18,549,111 |
RGD:6480464 |
CTD |
| G |
ITIH2 |
inter-alpha-trypsin inhibitor heavy chain 2 |
|
increases expression |
EXP |
10 |
7,745,236 |
7,791,483 |
RGD:6480464 |
CTD |
| G |
ITIH4 |
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
affects expression |
ISO |
3 |
52,847,006 |
52,864,717 |
RGD:6480464 |
CTD |
| G |
IVNS1ABP |
influenza virus NS1A binding protein |
|
increases expression |
ISO |
1 |
185,265,520 |
185,286,461 |
RGD:6480464 |
CTD |
| G |
JAK1 |
Janus kinase 1 |
|
affects expression |
ISO |
1 |
65,298,906 |
65,432,187 |
RGD:6480464 |
CTD |
| G |
JAKMIP3 |
Janus kinase and microtubule interacting protein 3 |
|
increases expression |
EXP |
10 |
133,918,313 |
133,998,313 |
RGD:6480464 |
CTD |
| G |
JRKL |
jerky homolog-like (mouse) |
|
increases expression |
EXP |
11 |
96,123,158 |
96,126,727 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
increases expression |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
KCNA4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
|
increases expression |
ISO |
11 |
30,031,288 |
30,038,577 |
RGD:6480464 |
CTD |
| G |
KCNA5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
|
decreases expression |
ISO |
12 |
5,153,085 |
5,155,954 |
RGD:6480464 |
CTD |
| G |
KCNA5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
|
decreases expression |
ISO |
12 |
5,153,085 |
5,155,954 |
RGD:6480464 |
CTD |
| G |
KCNA5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
|
decreases expression |
ISO |
12 |
5,153,085 |
5,155,954 |
RGD:6480464 |
CTD |
| G |
KCNAB1 |
potassium voltage-gated channel, shaker-related subfamily, beta member 1 |
|
increases expression |
ISO |
3 |
155,838,337 |
156,256,927 |
RGD:6480464 |
CTD |
| G |
KCNB1 |
potassium voltage-gated channel, Shab-related subfamily, member 1 |
|
decreases expression |
ISO |
20 |
47,988,505 |
48,099,181 |
RGD:6480464 |
CTD |
| G |
KCND2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
|
decreases expression |
ISO |
7 |
119,913,722 |
120,390,387 |
RGD:6480464 |
CTD |
| G |
KCNE1L |
KCNE1-like |
|
increases expression |
EXP |
X |
108,866,929 |
108,868,393 |
RGD:6480464 |
CTD |
| G |
KCNE3 |
potassium voltage-gated channel, Isk-related family, member 3 |
|
increases expression |
ISO |
11 |
74,165,886 |
74,178,600 |
RGD:6480464 |
CTD |
| G |
KCNH2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
decreases activity |
EXP |
7 |
150,642,044 |
150,675,402 |
RGD:6480464 |
CTD |
| G |
KCNH2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
decreases activity |
EXP |
7 |
150,642,044 |
150,675,402 |
RGD:6480464 |
CTD |
| G |
KCNH2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
multiple interactions |
EXP |
7 |
150,642,044 |
150,675,402 |
RGD:6480464 |
CTD |
| G |
KCNH2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
multiple interactions |
EXP |
7 |
150,642,044 |
150,675,402 |
RGD:6480464 |
CTD |
| G |
KCNH2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
decreases activity |
EXP |
7 |
150,642,044 |
150,675,402 |
RGD:6480464 |
CTD |
| G |
KCNH2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
multiple interactions |
EXP |
7 |
150,642,044 |
150,675,402 |
RGD:6480464 |
CTD |
| G |
KCNJ2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
|
increases expression |
EXP |
17 |
68,165,676 |
68,176,185 |
RGD:6480464 |
CTD |
| G |
KCNK1 |
potassium channel, subfamily K, member 1 |
|
increases expression |
ISO |
1 |
233,749,750 |
233,808,258 |
RGD:6480464 |
CTD |
| G |
KCNK12 |
potassium channel, subfamily K, member 12 |
|
increases expression |
EXP |
2 |
47,747,914 |
47,797,470 |
RGD:6480464 |
CTD |
| G |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
increases expression |
EXP |
10 |
78,629,359 |
79,397,577 |
RGD:6480464 |
CTD |
| G |
KCTD14 |
potassium channel tetramerisation domain containing 14 |
|
increases expression |
EXP |
11 |
77,726,761 |
77,734,320 |
RGD:6480464 |
CTD |
| G |
KDELR2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
affects expression |
ISO |
7 |
6,500,712 |
6,523,849 |
RGD:6480464 |
CTD |
| G |
KDELR2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
affects expression |
ISO |
7 |
6,500,712 |
6,523,849 |
RGD:6480464 |
CTD |
| G |
KDELR2 |
KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 |
|
affects expression |
ISO |
7 |
6,500,712 |
6,523,849 |
RGD:6480464 |
CTD |
| G |
KDR |
kinase insert domain receptor (a type III receptor tyrosine kinase) |
|
affects expression |
ISO |
4 |
55,944,426 |
55,991,762 |
RGD:6480464 |
CTD |
| G |
KEAP1 |
kelch-like ECH-associated protein 1 |
|
decreases expression |
ISO |
19 |
10,596,796 |
10,614,054 |
RGD:6480464 |
CTD |
| G |
KIAA0368 |
KIAA0368 |
|
decreases expression |
ISO |
9 |
114,122,973 |
114,247,025 |
RGD:6480464 |
CTD |
| G |
KIAA0368 |
KIAA0368 |
|
decreases expression |
ISO |
9 |
114,122,973 |
114,247,025 |
RGD:6480464 |
CTD |
| G |
KIF16B |
kinesin family member 16B |
|
increases expression |
EXP |
20 |
16,252,749 |
16,554,079 |
RGD:6480464 |
CTD |
| G |
KIF17 |
kinesin family member 17 |
|
increases expression |
EXP |
1 |
20,990,507 |
21,044,317 |
RGD:6480464 |
CTD |
| G |
KIFC1 |
kinesin family member C1 |
|
increases expression |
EXP |
6 |
33,359,313 |
33,377,701 |
RGD:6480464 |
CTD |
| G |
KIR2DL5B |
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
KITLG |
KIT ligand |
|
increases expression |
EXP |
12 |
88,886,570 |
88,974,250 |
RGD:6480464 |
CTD |
| G |
KLF10 |
Kruppel-like factor 10 |
|
increases expression |
EXP |
8 |
103,661,005 |
103,667,983 |
RGD:6480464 |
CTD |
| G |
KLF15 |
Kruppel-like factor 15 |
|
increases expression |
EXP |
3 |
126,061,478 |
126,076,236 |
RGD:6480464 |
CTD |
| G |
KLF16 |
Kruppel-like factor 16 |
|
increases expression |
EXP |
19 |
1,852,398 |
1,863,564 |
RGD:6480464 |
CTD |
| G |
KLF4 |
Kruppel-like factor 4 (gut) |
|
increases expression |
EXP |
9 |
110,247,133 |
110,252,047 |
RGD:6480464 |
CTD |
| G |
KLHL28 |
kelch-like family member 28 |
|
increases expression |
EXP |
14 |
45,393,527 |
45,431,179 |
RGD:6480464 |
CTD |
| G |
KLK14 |
kallikrein-related peptidase 14 |
|
increases expression |
EXP |
19 |
51,581,154 |
51,587,502 |
RGD:6480464 |
CTD |
| G |
KRT17 |
keratin 17 |
|
increases expression |
EXP |
17 |
39,775,692 |
39,780,882 |
RGD:6480464 |
CTD |
| G |
KRT8 |
keratin 8 |
|
affects expression |
ISO |
12 |
53,290,971 |
53,343,650 |
RGD:6480464 |
CTD |
| G |
L3MBTL1 |
l(3)mbt-like 1 (Drosophila) |
|
increases expression |
EXP |
20 |
42,136,320 |
42,170,535 |
RGD:6480464 |
CTD |
| G |
LACRT |
lacritin |
|
increases expression |
EXP |
12 |
55,024,623 |
55,028,663 |
RGD:6480464 |
CTD |
| G |
LCAT |
lecithin-cholesterol acyltransferase |
|
affects expression |
ISO |
16 |
67,973,787 |
67,978,015 |
RGD:6480464 |
CTD |
| G |
LCMT1 |
leucine carboxyl methyltransferase 1 |
|
affects expression |
ISO |
16 |
25,123,047 |
25,189,551 |
RGD:6480464 |
CTD |
| G |
LCTL |
lactase-like |
|
increases expression |
EXP |
15 |
66,840,536 |
66,857,835 |
RGD:6480464 |
CTD |
| G |
LDLR |
low density lipoprotein receptor |
|
decreases expression |
ISO |
19 |
11,200,038 |
11,244,506 |
RGD:6480464 |
CTD |
| G |
LDLR |
low density lipoprotein receptor |
|
decreases expression |
ISO |
19 |
11,200,038 |
11,244,506 |
RGD:6480464 |
CTD |
| G |
LDLR |
low density lipoprotein receptor |
|
multiple interactions |
EXP |
19 |
11,200,038 |
11,244,506 |
RGD:6480464 |
CTD |
| G |
LDLR |
low density lipoprotein receptor |
|
multiple interactions |
ISO |
19 |
11,200,038 |
11,244,506 |
RGD:6480464 |
CTD |
| G |
LDLR |
low density lipoprotein receptor |
|
decreases expression |
EXP |
19 |
11,200,038 |
11,244,506 |
RGD:6480464 |
CTD |
| G |
LDLR |
low density lipoprotein receptor |
|
decreases expression |
ISO |
19 |
11,200,038 |
11,244,506 |
RGD:6480464 |
CTD |
| G |
LDLR |
low density lipoprotein receptor |
|
decreases expression |
ISO |
19 |
11,200,038 |
11,244,506 |
RGD:6480464 |
CTD |
| G |
LELP1 |
late cornified envelope-like proline-rich 1 |
|
increases expression |
EXP |
1 |
153,175,919 |
153,177,596 |
RGD:6480464 |
CTD |
| G |
LHCGR |
luteinizing hormone/choriogonadotropin receptor |
|
increases expression |
EXP |
2 |
48,913,913 |
48,982,880 |
RGD:6480464 |
CTD |
| G |
LIF |
leukemia inhibitory factor |
|
increases expression |
EXP |
22 |
30,636,436 |
30,642,840 |
RGD:6480464 |
CTD |
| G |
LIMS3 |
LIM and senescent cell antigen-like domains 3 |
|
increases expression |
EXP |
2 |
110,656,009 |
110,683,202 |
RGD:6480464 |
CTD |
| G |
LIN7A |
lin-7 homolog A (C. elegans) |
|
increases expression |
EXP |
12 |
81,191,171 |
81,331,694 |
RGD:6480464 |
CTD |
| G |
LINC00472 |
long intergenic non-protein coding RNA 472 |
|
increases expression |
EXP |
6 |
72,124,149 |
72,130,448 |
RGD:6480464 |
CTD |
| G |
LINC00521 |
long intergenic non-protein coding RNA 521 |
|
increases expression |
EXP |
14 |
94,463,616 |
94,478,041 |
RGD:6480464 |
CTD |
| G |
LIPC |
lipase, hepatic |
|
affects expression |
ISO |
15 |
58,724,175 |
58,861,073 |
RGD:6480464 |
CTD |
| G |
LOX |
lysyl oxidase |
|
affects expression |
ISO |
5 |
121,398,890 |
121,414,055 |
RGD:6480464 |
CTD |
| G |
LRP3 |
low density lipoprotein receptor-related protein 3 |
|
affects expression |
ISO |
19 |
33,685,599 |
33,699,773 |
RGD:6480464 |
CTD |
| G |
LRP3 |
low density lipoprotein receptor-related protein 3 |
|
affects expression |
ISO |
19 |
33,685,599 |
33,699,773 |
RGD:6480464 |
CTD |
| G |
LRP5 |
low density lipoprotein receptor-related protein 5 |
|
increases expression |
EXP |
11 |
68,080,108 |
68,216,743 |
RGD:6480464 |
CTD |
| G |
LSMD1 |
LSM domain containing 1 |
|
affects expression |
ISO |
17 |
7,760,003 |
7,761,172 |
RGD:6480464 |
CTD |
| G |
LSS |
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
|
increases expression |
ISO |
21 |
47,608,360 |
47,648,738 |
RGD:6480464 |
CTD |
| G |
LSS |
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
|
increases expression |
EXP |
21 |
47,608,360 |
47,648,738 |
RGD:6480464 |
CTD |
| G |
LYZ |
lysozyme |
|
increases expression |
EXP |
12 |
69,742,134 |
69,748,013 |
RGD:6480464 |
CTD |
| G |
MACROD2 |
MACRO domain containing 2 |
|
increases expression |
EXP |
20 |
13,976,146 |
16,033,842 |
RGD:6480464 |
CTD |
| G |
MAFG |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) |
|
increases expression |
EXP |
17 |
79,876,145 |
79,885,587 |
RGD:6480464 |
CTD |
| G |
MAGED4B |
melanoma antigen family D, 4B |
|
increases expression |
EXP |
X |
51,804,923 |
51,812,368 |
RGD:6480464 |
CTD |
| G |
MAN2B1 |
mannosidase, alpha, class 2B, member 1 |
|
affects expression |
ISO |
19 |
12,757,322 |
12,777,591 |
RGD:6480464 |
CTD |
| G |
MANBA |
mannosidase, beta A, lysosomal |
|
affects expression |
ISO |
4 |
103,552,643 |
103,682,151 |
RGD:6480464 |
CTD |
| G |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
|
affects expression |
ISO |
19 |
4,090,319 |
4,124,126 |
RGD:6480464 |
CTD |
| G |
MASP1 |
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
|
increases expression |
EXP |
3 |
186,933,873 |
187,009,810 |
RGD:6480464 |
CTD |
| G |
MASP2 |
mannan-binding lectin serine peptidase 2 |
|
affects expression |
ISO |
1 |
11,086,580 |
11,107,296 |
RGD:6480464 |
CTD |
| G |
MCAM |
melanoma cell adhesion molecule |
|
increases expression |
EXP |
11 |
119,179,234 |
119,187,840 |
RGD:6480464 |
CTD |
| G |
MCF2 |
MCF.2 cell line derived transforming sequence |
|
increases expression |
EXP |
X |
138,663,930 |
138,790,381 |
RGD:6480464 |
CTD |
| G |
ME1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
increases expression |
ISO |
6 |
83,920,108 |
84,140,938 |
RGD:6480464 |
CTD |
| G |
ME1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
affects expression |
ISO |
6 |
83,920,108 |
84,140,938 |
RGD:6480464 |
CTD |
| G |
MED11 |
mediator complex subunit 11 |
|
increases expression |
EXP |
17 |
4,634,723 |
4,636,902 |
RGD:6480464 |
CTD |
| G |
MEF2C |
myocyte enhancer factor 2C |
|
increases expression |
EXP |
5 |
88,014,058 |
88,199,922 |
RGD:6480464 |
CTD |
| G |
MFHAS1 |
malignant fibrous histiocytoma amplified sequence 1 |
|
increases expression |
EXP |
8 |
8,641,999 |
8,751,131 |
RGD:6480464 |
CTD |
| G |
MFSD1 |
major facilitator superfamily domain containing 1 |
|
decreases expression |
ISO |
3 |
158,519,715 |
158,547,508 |
RGD:6480464 |
CTD |
| G |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
|
increases expression |
EXP |
2 |
99,235,569 |
99,347,589 |
RGD:6480464 |
CTD |
| G |
MGST1 |
microsomal glutathione S-transferase 1 |
|
increases expression |
EXP |
12 |
16,500,076 |
16,530,123 |
RGD:6480464 |
CTD |
| G |
MICALL2 |
MICAL-like 2 |
|
increases expression |
EXP |
7 |
1,473,995 |
1,499,109 |
RGD:6480464 |
CTD |
| G |
MID2 |
midline 2 |
|
increases expression |
EXP |
X |
107,069,084 |
107,174,867 |
RGD:6480464 |
CTD |
| G |
MITF |
microphthalmia-associated transcription factor |
|
increases expression |
EXP |
3 |
69,788,586 |
70,017,488 |
RGD:6480464 |
CTD |
| G |
MLX |
MLX, MAX dimerization protein |
|
affects expression |
ISO |
17 |
40,719,078 |
40,725,221 |
RGD:6480464 |
CTD |
| G |
MMP23A |
matrix metallopeptidase 23A (pseudogene) |
|
increases expression |
EXP |
1 |
1,631,378 |
1,633,247 |
RGD:6480464 |
CTD |
| G |
MORN5 |
MORN repeat containing 5 |
|
increases expression |
EXP |
9 |
124,922,190 |
124,962,367 |
RGD:6480464 |
CTD |
| G |
MPI |
mannose phosphate isomerase |
|
increases expression |
EXP |
15 |
75,182,410 |
75,190,565 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
multiple interactions |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MRO |
maestro |
|
affects expression |
ISO |
18 |
48,321,490 |
48,351,754 |
RGD:6480464 |
CTD |
| G |
MRO |
maestro |
|
affects expression |
ISO |
18 |
48,321,490 |
48,351,754 |
RGD:6480464 |
CTD |
| G |
MRPL10 |
mitochondrial ribosomal protein L10 |
|
increases expression |
EXP |
17 |
45,900,638 |
45,908,907 |
RGD:6480464 |
CTD |
| G |
MRPL2 |
mitochondrial ribosomal protein L2 |
|
affects expression |
ISO |
6 |
43,021,767 |
43,027,242 |
RGD:6480464 |
CTD |
| G |
MRPL9 |
mitochondrial ribosomal protein L9 |
|
affects expression |
ISO |
1 |
151,732,123 |
151,736,040 |
RGD:6480464 |
CTD |
| G |
MRPS18B |
mitochondrial ribosomal protein S18B |
|
affects expression |
ISO |
6 |
30,585,486 |
30,594,174 |
RGD:6480464 |
CTD |
| G |
MS4A14 |
membrane-spanning 4-domains, subfamily A, member 14 |
|
increases expression |
EXP |
11 |
60,163,487 |
60,185,229 |
RGD:6480464 |
CTD |
| G |
MSMO1 |
methylsterol monooxygenase 1 |
|
affects expression |
ISO |
4 |
166,248,818 |
166,264,316 |
RGD:6480464 |
CTD |
| G |
MT-CO3 |
mitochondrially encoded cytochrome c oxidase III |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
MT1F |
metallothionein 1F |
|
increases expression |
EXP |
16 |
56,691,855 |
56,693,215 |
RGD:6480464 |
CTD |
| G |
MT1G |
metallothionein 1G |
|
increases expression |
EXP |
16 |
56,700,653 |
56,701,977 |
RGD:6480464 |
CTD |
| G |
MT1X |
metallothionein 1X |
|
increases expression |
EXP |
16 |
56,716,382 |
56,718,108 |
RGD:6480464 |
CTD |
| G |
MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
EXP |
1 |
11,166,588 |
11,322,608 |
RGD:6480464 |
CTD |
| G |
MUT |
methylmalonyl CoA mutase |
|
affects expression |
ISO |
6 |
49,398,073 |
49,431,041 |
RGD:6480464 |
CTD |
| G |
MUT |
methylmalonyl CoA mutase |
|
affects expression |
ISO |
6 |
49,398,073 |
49,431,041 |
RGD:6480464 |
CTD |
| G |
MXD1 |
MAX dimerization protein 1 |
|
increases expression |
EXP |
2 |
70,142,173 |
70,170,077 |
RGD:6480464 |
CTD |
| G |
MYADM |
myeloid-associated differentiation marker |
|
affects expression |
ISO |
19 |
54,369,611 |
54,379,689 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
decreases expression |
ISO |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
MYCBP2 |
MYC binding protein 2, E3 ubiquitin protein ligase |
|
affects expression |
ISO |
13 |
77,618,792 |
77,901,177 |
RGD:6480464 |
CTD |
| G |
MYEF2 |
myelin expression factor 2 |
|
increases expression |
EXP |
15 |
48,431,629 |
48,470,558 |
RGD:6480464 |
CTD |
| G |
MYH11 |
myosin, heavy chain 11, smooth muscle |
|
increases expression |
EXP |
16 |
15,796,992 |
15,950,887 |
RGD:6480464 |
CTD |
| G |
MYH6 |
myosin, heavy chain 6, cardiac muscle, alpha |
|
decreases expression |
ISO |
14 |
23,851,199 |
23,877,486 |
RGD:6480464 |
CTD |
| G |
MYH7 |
myosin, heavy chain 7, cardiac muscle, beta |
|
increases expression |
ISO |
14 |
23,881,947 |
23,903,496 |
RGD:6480464 |
CTD |
| G |
MYL4 |
myosin, light chain 4, alkali; atrial, embryonic |
|
increases expression |
EXP |
17 |
45,286,428 |
45,301,045 |
RGD:6480464 |
CTD |
| G |
MYLK2 |
myosin light chain kinase 2 |
|
increases expression |
EXP |
20 |
30,407,178 |
30,422,500 |
RGD:6480464 |
CTD |
| G |
MYO1D |
myosin ID |
|
affects expression |
ISO |
17 |
30,819,628 |
31,203,902 |
RGD:6480464 |
CTD |
| G |
MYO3A |
myosin IIIA |
|
increases expression |
EXP |
10 |
26,223,002 |
26,501,465 |
RGD:6480464 |
CTD |
| G |
N4BP3 |
NEDD4 binding protein 3 |
|
increases expression |
EXP |
5 |
177,540,556 |
177,553,107 |
RGD:6480464 |
CTD |
| G |
NAA16 |
N(alpha)-acetyltransferase 16, NatA auxiliary subunit |
|
increases expression |
EXP |
13 |
41,885,341 |
41,951,166 |
RGD:6480464 |
CTD |
| G |
NANOS1 |
nanos homolog 1 (Drosophila) |
|
increases expression |
EXP |
10 |
120,789,228 |
120,793,854 |
RGD:6480464 |
CTD |
| G |
NAP1L1 |
nucleosome assembly protein 1-like 1 |
|
affects expression |
ISO |
12 |
76,438,672 |
76,478,738 |
RGD:6480464 |
CTD |
| G |
NAPSA |
napsin A aspartic peptidase |
|
decreases expression |
ISO |
19 |
50,861,734 |
50,868,931 |
RGD:6480464 |
CTD |
| G |
NAT8 |
N-acetyltransferase 8 (GCN5-related, putative) |
|
affects expression |
ISO |
2 |
73,867,850 |
73,869,537 |
RGD:6480464 |
CTD |
| G |
NBPF3 |
neuroblastoma breakpoint family, member 3 |
|
increases expression |
EXP |
1 |
21,766,621 |
21,811,393 |
RGD:6480464 |
CTD |
| G |
NDRG2 |
NDRG family member 2 |
|
decreases expression |
ISO |
14 |
21,484,922 |
21,493,935 |
RGD:6480464 |
CTD |
| G |
NDRG2 |
NDRG family member 2 |
|
affects expression |
ISO |
14 |
21,484,922 |
21,493,935 |
RGD:6480464 |
CTD |
| G |
NDUFS5 |
NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) |
|
affects expression |
ISO |
1 |
39,491,967 |
39,500,308 |
RGD:6480464 |
CTD |
| G |
NDUFS5 |
NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) |
|
affects expression |
ISO |
1 |
39,491,967 |
39,500,308 |
RGD:6480464 |
CTD |
| G |
NDUFV3 |
NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa |
|
affects expression |
ISO |
21 |
44,313,378 |
44,329,773 |
RGD:6480464 |
CTD |
| G |
NEK8 |
NIMA-related kinase 8 |
|
increases expression |
EXP |
17 |
27,055,832 |
27,069,784 |
RGD:6480464 |
CTD |
| G |
NEU2 |
sialidase 2 (cytosolic sialidase) |
|
affects expression |
ISO |
2 |
233,897,382 |
233,899,767 |
RGD:6480464 |
CTD |
| G |
NF2 |
neurofibromin 2 (merlin) |
|
increases expression |
EXP |
22 |
29,999,545 |
30,094,589 |
RGD:6480464 |
CTD |
| G |
NFIC |
nuclear factor I/C (CCAAT-binding transcription factor) |
|
increases expression |
EXP |
19 |
3,359,561 |
3,469,215 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases expression |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIZ |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
|
increases expression |
EXP |
3 |
101,546,834 |
101,579,869 |
RGD:6480464 |
CTD |
| G |
NFX1 |
nuclear transcription factor, X-box binding 1 |
|
affects expression |
ISO |
9 |
33,290,418 |
33,371,155 |
RGD:6480464 |
CTD |
| G |
NIT1 |
nitrilase 1 |
|
affects expression |
ISO |
1 |
161,087,862 |
161,095,235 |
RGD:6480464 |
CTD |
| G |
NME2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
affects expression |
ISO |
17 |
49,242,796 |
49,249,105 |
RGD:6480464 |
CTD |
| G |
NME8 |
NME/NM23 family member 8 |
|
increases expression |
EXP |
7 |
37,888,199 |
37,940,003 |
RGD:6480464 |
CTD |
| G |
NNT |
nicotinamide nucleotide transhydrogenase |
|
increases expression |
ISO |
5 |
43,602,791 |
43,705,668 |
RGD:6480464 |
CTD |
| G |
NOL6 |
nucleolar protein 6 (RNA-associated) |
|
increases expression |
EXP |
9 |
33,461,351 |
33,473,941 |
RGD:6480464 |
CTD |
| G |
NOS1AP |
nitric oxide synthase 1 (neuronal) adaptor protein |
|
increases expression |
EXP |
1 |
162,039,581 |
162,339,813 |
RGD:6480464 |
CTD |
| G |
NOS3 |
nitric oxide synthase 3 (endothelial cell) |
|
multiple interactions |
EXP |
7 |
150,688,144 |
150,711,687 |
RGD:6480464 |
CTD |
| G |
NPPA |
natriuretic peptide A |
|
increases expression |
ISO |
1 |
11,905,766 |
11,907,840 |
RGD:6480464 |
CTD |
| G |
NPSR1 |
neuropeptide S receptor 1 |
|
increases expression |
EXP |
7 |
34,697,897 |
34,917,944 |
RGD:6480464 |
CTD |
| G |
NPTXR |
neuronal pentraxin receptor |
|
increases expression |
EXP |
22 |
39,214,456 |
39,240,017 |
RGD:6480464 |
CTD |
| G |
NR1I3 |
nuclear receptor subfamily 1, group I, member 3 |
|
affects expression |
ISO |
1 |
161,199,456 |
161,208,000 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
affects expression |
ISO |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NR4A2 |
nuclear receptor subfamily 4, group A, member 2 |
|
increases expression |
EXP |
2 |
157,180,944 |
157,189,287 |
RGD:6480464 |
CTD |
| G |
NREP |
neuronal regeneration related protein |
|
affects expression |
ISO |
5 |
111,065,000 |
111,312,628 |
RGD:6480464 |
CTD |
| G |
NT5M |
5',3'-nucleotidase, mitochondrial |
|
increases expression |
EXP |
17 |
17,206,680 |
17,250,977 |
RGD:6480464 |
CTD |
| G |
NTRK3 |
neurotrophic tyrosine kinase, receptor, type 3 |
|
increases expression |
EXP |
15 |
88,419,988 |
88,799,962 |
RGD:6480464 |
CTD |
| G |
NUPR1 |
nuclear protein, transcriptional regulator, 1 |
|
increases expression |
EXP |
16 |
28,548,662 |
28,550,495 |
RGD:6480464 |
CTD |
| G |
OAF |
OAF homolog (Drosophila) |
|
affects expression |
ISO |
11 |
120,081,747 |
120,100,650 |
RGD:6480464 |
CTD |
| G |
OCM |
oncomodulin |
|
increases expression |
EXP |
7 |
5,920,429 |
5,925,994 |
RGD:6480464 |
CTD |
| G |
OGDH |
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
|
affects expression |
ISO |
7 |
44,646,121 |
44,748,669 |
RGD:6480464 |
CTD |
| G |
OPHN1 |
oligophrenin 1 |
|
increases expression |
EXP |
X |
67,262,186 |
67,653,299 |
RGD:6480464 |
CTD |
| G |
OR14I1 |
olfactory receptor, family 14, subfamily I, member 1 |
|
increases expression |
EXP |
1 |
248,844,670 |
248,845,605 |
RGD:6480464 |
CTD |
| G |
OR2B2 |
olfactory receptor, family 2, subfamily B, member 2 |
|
increases expression |
EXP |
6 |
27,878,963 |
27,880,174 |
RGD:6480464 |
CTD |
| G |
OR2D2 |
olfactory receptor, family 2, subfamily D, member 2 |
|
increases expression |
EXP |
11 |
6,912,805 |
6,913,731 |
RGD:6480464 |
CTD |
| G |
OR4C16 |
olfactory receptor, family 4, subfamily C, member 16 |
|
increases expression |
EXP |
11 |
55,339,604 |
55,340,536 |
RGD:6480464 |
CTD |
| G |
OR4F5 |
olfactory receptor, family 4, subfamily F, member 5 |
|
increases expression |
EXP |
1 |
69,091 |
70,008 |
RGD:6480464 |
CTD |
| G |
OR51E2 |
olfactory receptor, family 51, subfamily E, member 2 |
|
affects expression |
ISO |
11 |
4,701,401 |
4,719,076 |
RGD:6480464 |
CTD |
| G |
OR52N2 |
olfactory receptor, family 52, subfamily N, member 2 |
|
increases expression |
EXP |
11 |
5,841,566 |
5,842,531 |
RGD:6480464 |
CTD |
| G |
OR6T1 |
olfactory receptor, family 6, subfamily T, member 1 |
|
increases expression |
EXP |
11 |
123,813,574 |
123,814,545 |
RGD:6480464 |
CTD |
| G |
OR9Q2 |
olfactory receptor, family 9, subfamily Q, member 2 |
|
increases expression |
EXP |
11 |
57,957,906 |
57,958,990 |
RGD:6480464 |
CTD |
| G |
OSBP2 |
oxysterol binding protein 2 |
|
increases expression |
EXP |
22 |
31,090,793 |
31,303,811 |
RGD:6480464 |
CTD |
| G |
OSTC |
oligosaccharyltransferase complex subunit (non-catalytic) |
|
affects expression |
ISO |
4 |
109,571,741 |
109,588,978 |
RGD:6480464 |
CTD |
| G |
OTC |
ornithine carbamoyltransferase |
|
affects expression |
ISO |
X |
38,211,736 |
38,280,703 |
RGD:6480464 |
CTD |
| G |
OXCT1 |
3-oxoacid CoA transferase 1 |
|
increases expression |
ISO |
5 |
41,730,167 |
41,870,791 |
RGD:6480464 |
CTD |
| G |
OXSM |
3-oxoacyl-ACP synthase, mitochondrial |
|
increases expression |
EXP |
3 |
25,831,563 |
25,836,025 |
RGD:6480464 |
CTD |
| G |
PABPC4 |
poly(A) binding protein, cytoplasmic 4 (inducible form) |
|
affects expression |
ISO |
1 |
40,026,485 |
40,042,521 |
RGD:6480464 |
CTD |
| G |
PAICS |
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase |
|
affects expression |
ISO |
4 |
57,301,915 |
57,327,534 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PAX3 |
paired box 3 |
|
increases expression |
EXP |
2 |
223,064,606 |
223,163,715 |
RGD:6480464 |
CTD |
| G |
PC |
pyruvate carboxylase |
|
affects expression |
ISO |
11 |
66,615,997 |
66,725,847 |
RGD:6480464 |
CTD |
| G |
PC |
pyruvate carboxylase |
|
affects expression |
ISO |
11 |
66,615,997 |
66,725,847 |
RGD:6480464 |
CTD |
| G |
PCCB |
propionyl CoA carboxylase, beta polypeptide |
|
affects expression |
ISO |
3 |
135,969,167 |
136,049,013 |
RGD:6480464 |
CTD |
| G |
PCDH1 |
protocadherin 1 |
|
increases expression |
EXP |
5 |
141,232,672 |
141,257,944 |
RGD:6480464 |
CTD |
| G |
PCDH7 |
protocadherin 7 |
|
increases expression |
EXP |
4 |
30,722,030 |
31,148,423 |
RGD:6480464 |
CTD |
| G |
PCDH8 |
protocadherin 8 |
|
increases expression |
EXP |
13 |
53,418,109 |
53,422,775 |
RGD:6480464 |
CTD |
| G |
PCDHAC2 |
protocadherin alpha subfamily C, 2 |
|
increases expression |
EXP |
5 |
140,345,747 |
140,391,929 |
RGD:6480464 |
CTD |
| G |
PCDHGC3 |
protocadherin gamma subfamily C, 3 |
|
increases expression |
EXP |
5 |
140,855,569 |
140,892,546 |
RGD:6480464 |
CTD |
| G |
PCNA |
proliferating cell nuclear antigen |
|
decreases expression |
ISO |
20 |
5,095,599 |
5,107,268 |
RGD:6480464 |
CTD |
| G |
PCSK6 |
proprotein convertase subtilisin/kexin type 6 |
|
affects expression |
ISO |
15 |
101,844,133 |
102,030,187 |
RGD:6480464 |
CTD |
| G |
PCSK9 |
proprotein convertase subtilisin/kexin type 9 |
|
increases expression |
EXP |
1 |
55,505,149 |
55,530,526 |
RGD:6480464 |
CTD |
| G |
PCTP |
phosphatidylcholine transfer protein |
|
affects expression |
ISO |
17 |
53,828,340 |
53,854,748 |
RGD:6480464 |
CTD |
| G |
PDCD10 |
programmed cell death 10 |
|
increases expression |
EXP |
3 |
167,401,694 |
167,452,651 |
RGD:6480464 |
CTD |
| G |
PDCL3 |
phosducin-like 3 |
|
affects expression |
ISO |
2 |
101,179,418 |
101,193,201 |
RGD:6480464 |
CTD |
| G |
PDE6G |
phosphodiesterase 6G, cGMP-specific, rod, gamma |
|
increases expression |
EXP |
17 |
79,617,489 |
79,623,607 |
RGD:6480464 |
CTD |
| G |
PDE7B |
phosphodiesterase 7B |
|
increases expression |
EXP |
6 |
136,172,834 |
136,516,709 |
RGD:6480464 |
CTD |
| G |
PDF |
peptide deformylase (mitochondrial) |
|
increases expression |
EXP |
16 |
69,362,524 |
69,364,498 |
RGD:6480464 |
CTD |
| G |
PDGFRL |
platelet-derived growth factor receptor-like |
|
increases expression |
EXP |
8 |
17,433,942 |
17,500,642 |
RGD:6480464 |
CTD |
| G |
PDIA3 |
protein disulfide isomerase family A, member 3 |
|
affects expression |
ISO |
15 |
44,038,590 |
44,064,804 |
RGD:6480464 |
CTD |
| G |
PDIA6 |
protein disulfide isomerase family A, member 6 |
|
affects expression |
ISO |
2 |
10,923,517 |
10,952,960 |
RGD:6480464 |
CTD |
| G |
PDLIM2 |
PDZ and LIM domain 2 (mystique) |
|
increases expression |
EXP |
8 |
22,436,254 |
22,455,538 |
RGD:6480464 |
CTD |
| G |
PDYN |
prodynorphin |
|
increases expression |
EXP |
20 |
1,959,402 |
1,974,931 |
RGD:6480464 |
CTD |
| G |
PECR |
peroxisomal trans-2-enoyl-CoA reductase |
|
affects expression |
ISO |
2 |
216,903,111 |
216,946,539 |
RGD:6480464 |
CTD |
| G |
PER1 |
period circadian clock 1 |
|
increases expression |
EXP |
17 |
8,043,788 |
8,055,753 |
RGD:6480464 |
CTD |
| G |
PEX19 |
peroxisomal biogenesis factor 19 |
|
affects expression |
ISO |
1 |
160,246,599 |
160,254,941 |
RGD:6480464 |
CTD |
| G |
PEX19 |
peroxisomal biogenesis factor 19 |
|
affects expression |
ISO |
1 |
160,246,599 |
160,254,941 |
RGD:6480464 |
CTD |
| G |
PGAM1 |
phosphoglycerate mutase 1 (brain) |
|
affects expression |
ISO |
10 |
99,186,027 |
99,193,198 |
RGD:6480464 |
CTD |
| G |
PGK2 |
phosphoglycerate kinase 2 |
|
increases expression |
EXP |
6 |
49,753,364 |
49,755,053 |
RGD:6480464 |
CTD |
| G |
PGRMC1 |
progesterone receptor membrane component 1 |
|
affects expression |
ISO |
X |
118,370,211 |
118,378,429 |
RGD:6480464 |
CTD |
| G |
PHF20L1 |
PHD finger protein 20-like 1 |
|
increases expression |
EXP |
8 |
133,787,604 |
133,861,052 |
RGD:6480464 |
CTD |
| G |
PHF5A |
PHD finger protein 5A |
|
increases expression |
EXP |
22 |
41,855,721 |
41,864,708 |
RGD:6480464 |
CTD |
| G |
PHKA1 |
phosphorylase kinase, alpha 1 (muscle) |
|
increases expression |
EXP |
X |
71,798,664 |
71,934,029 |
RGD:6480464 |
CTD |
| G |
PHYH |
phytanoyl-CoA 2-hydroxylase |
|
affects expression |
ISO |
10 |
13,319,796 |
13,342,130 |
RGD:6480464 |
CTD |
| G |
PIFO |
primary cilia formation |
|
increases expression |
EXP |
1 |
111,889,195 |
111,895,639 |
RGD:6480464 |
CTD |
| G |
PIGA |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
increases expression |
EXP |
X |
15,337,573 |
15,353,676 |
RGD:6480464 |
CTD |
| G |
PIGP |
phosphatidylinositol glycan anchor biosynthesis, class P |
|
affects expression |
ISO |
21 |
38,437,664 |
38,445,458 |
RGD:6480464 |
CTD |
| G |
PIGP |
phosphatidylinositol glycan anchor biosynthesis, class P |
|
affects expression |
ISO |
21 |
38,437,664 |
38,445,458 |
RGD:6480464 |
CTD |
| G |
PIP5K1A |
phosphatidylinositol-4-phosphate 5-kinase, type I, alpha |
|
increases expression |
EXP |
1 |
151,171,021 |
151,222,007 |
RGD:6480464 |
CTD |
| G |
PKLR |
pyruvate kinase, liver and RBC |
|
affects expression |
ISO |
1 |
155,259,084 |
155,271,225 |
RGD:6480464 |
CTD |
| G |
PLAA |
phospholipase A2-activating protein |
|
increases expression |
EXP |
9 |
26,903,368 |
26,947,468 |
RGD:6480464 |
CTD |
| G |
PLAC8L1 |
PLAC8-like 1 |
|
increases expression |
EXP |
5 |
145,463,876 |
145,483,946 |
RGD:6480464 |
CTD |
| G |
PLBD1 |
phospholipase B domain containing 1 |
|
affects expression |
ISO |
12 |
14,656,597 |
14,720,791 |
RGD:6480464 |
CTD |
| G |
PLCG1 |
phospholipase C, gamma 1 |
|
decreases expression |
ISO |
20 |
39,766,161 |
39,804,357 |
RGD:6480464 |
CTD |
| G |
PLEKHG4 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 4 |
|
increases expression |
EXP |
16 |
67,311,413 |
67,323,403 |
RGD:6480464 |
CTD |
| G |
PLG |
plasminogen |
|
affects expression |
ISO |
6 |
161,123,225 |
161,175,086 |
RGD:6480464 |
CTD |
| G |
PLS1 |
plastin 1 |
|
increases expression |
EXP |
3 |
142,315,229 |
142,432,506 |
RGD:6480464 |
CTD |
| G |
PLS3 |
plastin 3 |
|
affects expression |
ISO |
X |
114,795,177 |
114,885,181 |
RGD:6480464 |
CTD |
| G |
PODN |
podocan |
|
increases expression |
EXP |
1 |
53,527,724 |
53,551,174 |
RGD:6480464 |
CTD |
| G |
POLL |
polymerase (DNA directed), lambda |
|
increases expression |
EXP |
10 |
103,338,639 |
103,348,027 |
RGD:6480464 |
CTD |
| G |
PON2 |
paraoxonase 2 |
|
affects expression |
ISO |
7 |
95,034,174 |
95,064,384 |
RGD:6480464 |
CTD |
| G |
POR |
P450 (cytochrome) oxidoreductase |
|
affects expression |
ISO |
7 |
75,544,420 |
75,616,173 |
RGD:6480464 |
CTD |
| G |
POTEH |
POTE ankyrin domain family, member H |
|
increases expression |
EXP |
22 |
16,256,332 |
16,287,937 |
RGD:6480464 |
CTD |
| G |
PPARA |
peroxisome proliferator-activated receptor alpha |
|
increases expression |
ISO |
22 |
46,546,499 |
46,639,653 |
RGD:6480464 |
CTD |
| G |
PPARA |
peroxisome proliferator-activated receptor alpha |
|
increases response to substance |
ISO |
22 |
46,546,499 |
46,639,653 |
RGD:6480464 |
CTD |
| G |
PPARG |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
3 |
12,329,349 |
12,475,855 |
RGD:6480464 |
CTD |
| G |
PPARG |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
EXP |
3 |
12,329,349 |
12,475,855 |
RGD:6480464 |
CTD |
| G |
PPDPF |
pancreatic progenitor cell differentiation and proliferation factor homolog (zebrafish) |
|
affects expression |
ISO |
20 |
62,152,133 |
62,153,524 |
RGD:6480464 |
CTD |
| G |
PPM1B |
protein phosphatase, Mg2+/Mn2+ dependent, 1B |
|
increases expression |
EXP |
2 |
44,396,000 |
44,461,742 |
RGD:6480464 |
CTD |
| G |
PPP1R15A |
protein phosphatase 1, regulatory subunit 15A |
|
increases expression |
EXP |
19 |
49,375,649 |
49,379,319 |
RGD:6480464 |
CTD |
| G |
PPP2R5C |
protein phosphatase 2, regulatory subunit B', gamma |
|
increases expression |
EXP |
14 |
102,228,135 |
102,394,329 |
RGD:6480464 |
CTD |
| G |
PPP3R1 |
protein phosphatase 3, regulatory subunit B, alpha |
|
increases expression |
EXP |
2 |
68,405,989 |
68,479,651 |
RGD:6480464 |
CTD |
| G |
PQLC1 |
PQ loop repeat containing 1 |
|
affects expression |
ISO |
18 |
77,662,420 |
77,711,653 |
RGD:6480464 |
CTD |
| G |
PRDM2 |
PR domain containing 2, with ZNF domain |
|
increases expression |
EXP |
1 |
14,026,735 |
14,151,574 |
RGD:6480464 |
CTD |
| G |
PRDM8 |
PR domain containing 8 |
|
increases expression |
EXP |
4 |
81,106,424 |
81,125,483 |
RGD:6480464 |
CTD |
| G |
PRDX2 |
peroxiredoxin 2 |
|
affects expression |
ISO |
19 |
12,907,634 |
12,912,694 |
RGD:6480464 |
CTD |
| G |
PRDX6 |
peroxiredoxin 6 |
|
affects expression |
ISO |
1 |
173,446,486 |
173,457,946 |
RGD:6480464 |
CTD |
| G |
PRIM2 |
primase, DNA, polypeptide 2 (58kDa) |
|
increases expression |
EXP |
6 |
57,182,415 |
57,512,702 |
RGD:6480464 |
CTD |
| G |
PRL |
prolactin |
|
decreases expression |
ISO |
6 |
22,287,473 |
22,303,082 |
RGD:6480464 |
CTD |
| G |
PRMT1 |
protein arginine methyltransferase 1 |
|
increases expression |
EXP |
19 |
50,180,409 |
50,191,707 |
RGD:6480464 |
CTD |
| G |
PROC |
protein C (inactivator of coagulation factors Va and VIIIa) |
|
affects expression |
ISO |
2 |
128,175,996 |
128,186,822 |
RGD:6480464 |
CTD |
| G |
PROSER2 |
proline and serine-rich protein 2 |
|
increases expression |
EXP |
10 |
11,865,397 |
11,914,276 |
RGD:6480464 |
CTD |
| G |
PROX1 |
prospero homeobox 1 |
|
increases expression |
EXP |
1 |
214,161,278 |
214,214,853 |
RGD:6480464 |
CTD |
| G |
PRPSAP1 |
phosphoribosyl pyrophosphate synthetase-associated protein 1 |
|
affects expression |
ISO |
17 |
74,306,868 |
74,350,230 |
RGD:6480464 |
CTD |
| G |
PRR19 |
proline rich 19 |
|
increases expression |
EXP |
19 |
42,806,284 |
42,814,973 |
RGD:6480464 |
CTD |
| G |
PSCA |
prostate stem cell antigen |
|
decreases expression |
ISO |
8 |
143,751,726 |
143,764,145 |
RGD:6480464 |
CTD |
| G |
PSCA |
prostate stem cell antigen |
|
decreases expression |
ISO |
8 |
143,751,726 |
143,764,145 |
RGD:6480464 |
CTD |
| G |
PSEN1 |
presenilin 1 |
|
increases expression |
EXP |
14 |
73,603,143 |
73,690,399 |
RGD:6480464 |
CTD |
| G |
PSIP1 |
PC4 and SFRS1 interacting protein 1 |
|
increases expression |
EXP |
9 |
15,464,064 |
15,511,003 |
RGD:6480464 |
CTD |
| G |
PSMA6 |
proteasome (prosome, macropain) subunit, alpha type, 6 |
|
affects expression |
ISO |
14 |
35,761,574 |
35,786,680 |
RGD:6480464 |
CTD |
| G |
PSMB1 |
proteasome (prosome, macropain) subunit, beta type, 1 |
|
affects expression |
ISO |
6 |
170,844,204 |
170,862,417 |
RGD:6480464 |
CTD |
| G |
PSMB3 |
proteasome (prosome, macropain) subunit, beta type, 3 |
|
affects expression |
ISO |
17 |
36,909,002 |
36,920,478 |
RGD:6480464 |
CTD |
| G |
PSMC1 |
proteasome (prosome, macropain) 26S subunit, ATPase, 1 |
|
affects expression |
ISO |
14 |
90,722,894 |
90,738,966 |
RGD:6480464 |
CTD |
| G |
PSMC3 |
proteasome (prosome, macropain) 26S subunit, ATPase, 3 |
|
affects expression |
ISO |
11 |
47,440,320 |
47,448,024 |
RGD:6480464 |
CTD |
| G |
PSMC5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
affects expression |
ISO |
17 |
61,904,770 |
61,909,387 |
RGD:6480464 |
CTD |
| G |
PSMD1 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 |
|
affects expression |
ISO |
2 |
231,921,578 |
232,037,541 |
RGD:6480464 |
CTD |
| G |
PSMD11 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 |
|
increases expression |
EXP |
17 |
30,771,481 |
30,810,337 |
RGD:6480464 |
CTD |
| G |
PSMD4 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 |
|
affects expression |
ISO |
1 |
151,227,197 |
151,239,955 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTMS |
parathymosin |
|
affects expression |
ISO |
12 |
6,875,541 |
6,880,118 |
RGD:6480464 |
CTD |
| G |
PTPN3 |
protein tyrosine phosphatase, non-receptor type 3 |
|
increases expression |
EXP |
9 |
112,137,974 |
112,260,593 |
RGD:6480464 |
CTD |
| G |
PTPRF |
protein tyrosine phosphatase, receptor type, F |
|
increases expression |
EXP |
1 |
43,996,547 |
44,089,343 |
RGD:6480464 |
CTD |
| G |
PTPRF |
protein tyrosine phosphatase, receptor type, F |
|
affects expression |
ISO |
1 |
43,996,547 |
44,089,343 |
RGD:6480464 |
CTD |
| G |
PTPRN |
protein tyrosine phosphatase, receptor type, N |
|
increases expression |
EXP |
2 |
220,154,345 |
220,174,295 |
RGD:6480464 |
CTD |
| G |
PTTG1IP |
pituitary tumor-transforming 1 interacting protein |
|
affects expression |
ISO |
21 |
46,269,500 |
46,293,818 |
RGD:6480464 |
CTD |
| G |
PYGL |
phosphorylase, glycogen, liver |
|
affects expression |
ISO |
14 |
51,371,935 |
51,411,248 |
RGD:6480464 |
CTD |
| G |
PYGO1 |
pygopus homolog 1 (Drosophila) |
|
increases expression |
EXP |
15 |
55,838,221 |
55,881,050 |
RGD:6480464 |
CTD |
| G |
PZP |
pregnancy-zone protein |
|
affects expression |
ISO |
12 |
9,301,436 |
9,360,966 |
RGD:6480464 |
CTD |
| G |
RAB39B |
RAB39B, member RAS oncogene family |
|
increases expression |
EXP |
X |
154,487,526 |
154,493,852 |
RGD:6480464 |
CTD |
| G |
RAB9B |
RAB9B, member RAS oncogene family |
|
increases expression |
EXP |
X |
103,077,255 |
103,087,212 |
RGD:6480464 |
CTD |
| G |
RAC3 |
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
|
increases expression |
EXP |
17 |
79,989,532 |
79,992,080 |
RGD:6480464 |
CTD |
| G |
RBBP8 |
retinoblastoma binding protein 8 |
|
increases expression |
EXP |
18 |
20,513,295 |
20,606,449 |
RGD:6480464 |
CTD |
| G |
RBKS |
ribokinase |
|
increases expression |
EXP |
2 |
28,004,266 |
28,113,223 |
RGD:6480464 |
CTD |
| G |
RBL2 |
retinoblastoma-like 2 (p130) |
|
affects expression |
ISO |
16 |
53,468,351 |
53,525,560 |
RGD:6480464 |
CTD |
| G |
RBM33 |
RNA binding motif protein 33 |
|
increases expression |
EXP |
7 |
155,437,203 |
155,574,179 |
RGD:6480464 |
CTD |
| G |
RBPMS |
RNA binding protein with multiple splicing |
|
increases expression |
EXP |
8 |
30,241,944 |
30,429,734 |
RGD:6480464 |
CTD |
| G |
RCN3 |
reticulocalbin 3, EF-hand calcium binding domain |
|
increases expression |
EXP |
19 |
50,030,875 |
50,046,890 |
RGD:6480464 |
CTD |
| G |
RDH8 |
retinol dehydrogenase 8 (all-trans) |
|
increases expression |
EXP |
19 |
10,123,925 |
10,132,954 |
RGD:6480464 |
CTD |
| G |
RELB |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
increases expression |
EXP |
19 |
45,504,707 |
45,541,456 |
RGD:6480464 |
CTD |
| G |
REPIN1 |
replication initiator 1 |
|
increases expression |
EXP |
7 |
150,065,879 |
150,071,133 |
RGD:6480464 |
CTD |
| G |
RGN |
regucalcin (senescence marker protein-30) |
|
decreases expression |
ISO |
X |
46,937,775 |
46,952,712 |
RGD:6480464 |
CTD |
| G |
RGS6 |
regulator of G-protein signaling 6 |
|
increases expression |
EXP |
14 |
72,398,817 |
73,033,238 |
RGD:6480464 |
CTD |
| G |
RHEBL1 |
Ras homolog enriched in brain like 1 |
|
increases expression |
EXP |
12 |
49,458,468 |
49,463,775 |
RGD:6480464 |
CTD |
| G |
RIN3 |
Ras and Rab interactor 3 |
|
increases expression |
EXP |
14 |
92,980,125 |
93,155,336 |
RGD:6480464 |
CTD |
| G |
RNASE4 |
ribonuclease, RNase A family, 4 |
|
affects expression |
ISO |
14 |
21,152,372 |
21,168,758 |
RGD:6480464 |
CTD |
| G |
RNF103 |
ring finger protein 103 |
|
affects expression |
ISO |
2 |
86,830,516 |
86,851,000 |
RGD:6480464 |
CTD |
| G |
RNF146 |
ring finger protein 146 |
|
increases expression |
EXP |
6 |
127,587,827 |
127,609,707 |
RGD:6480464 |
CTD |
| G |
RNF19A |
ring finger protein 19A, E3 ubiquitin protein ligase |
|
increases expression |
EXP |
8 |
101,269,288 |
101,322,379 |
RGD:6480464 |
CTD |
| G |
RNF212 |
ring finger protein 212 |
|
increases expression |
EXP |
4 |
1,065,266 |
1,107,352 |
RGD:6480464 |
CTD |
| G |
RNF6 |
ring finger protein (C3H2C3 type) 6 |
|
increases expression |
EXP |
13 |
26,786,905 |
26,796,508 |
RGD:6480464 |
CTD |
| G |
RNF8 |
ring finger protein 8, E3 ubiquitin protein ligase |
|
increases expression |
EXP |
6 |
37,321,748 |
37,362,514 |
RGD:6480464 |
CTD |
| G |
RNPS1 |
RNA binding protein S1, serine-rich domain |
|
affects expression |
ISO |
16 |
2,303,100 |
2,318,413 |
RGD:6480464 |
CTD |
| G |
RPL11 |
ribosomal protein L11 |
|
affects expression |
ISO |
1 |
24,018,269 |
24,022,915 |
RGD:6480464 |
CTD |
| G |
RPL13 |
ribosomal protein L13 |
|
affects expression |
ISO |
16 |
89,627,065 |
89,633,237 |
RGD:6480464 |
CTD |
| G |
RPL15 |
ribosomal protein L15 |
|
affects expression |
ISO |
3 |
23,958,295 |
23,965,187 |
RGD:6480464 |
CTD |
| G |
RPL17 |
ribosomal protein L17 |
|
affects expression |
ISO |
18 |
47,014,851 |
47,018,935 |
RGD:6480464 |
CTD |
| G |
RPL17 |
ribosomal protein L17 |
|
affects expression |
ISO |
18 |
47,014,851 |
47,018,935 |
RGD:6480464 |
CTD |
| G |
RPL23 |
ribosomal protein L23 |
|
affects expression |
ISO |
17 |
37,006,321 |
37,010,053 |
RGD:6480464 |
CTD |
| G |
RPL3 |
ribosomal protein L3 |
|
affects expression |
ISO |
22 |
39,708,887 |
39,715,670 |
RGD:6480464 |
CTD |
| G |
RPL32 |
ribosomal protein L32 |
|
affects expression |
ISO |
3 |
12,876,444 |
12,883,081 |
RGD:6480464 |
CTD |
| G |
RPL36A |
ribosomal protein L36a |
|
increases expression |
EXP |
X |
100,645,878 |
100,651,142 |
RGD:6480464 |
CTD |
| G |
RPL4 |
ribosomal protein L4 |
|
affects expression |
ISO |
15 |
66,791,653 |
66,797,193 |
RGD:6480464 |
CTD |
| G |
RPN2 |
ribophorin II |
|
affects expression |
ISO |
20 |
35,807,456 |
35,870,026 |
RGD:6480464 |
CTD |
| G |
RPS14 |
ribosomal protein S14 |
|
affects expression |
ISO |
5 |
149,823,792 |
149,829,319 |
RGD:6480464 |
CTD |
| G |
RPS18 |
ribosomal protein S18 |
|
affects expression |
ISO |
6 |
33,239,852 |
33,244,281 |
RGD:6480464 |
CTD |
| G |
RPS19 |
ribosomal protein S19 |
|
affects expression |
ISO |
19 |
42,363,988 |
42,375,484 |
RGD:6480464 |
CTD |
| G |
RPS20 |
ribosomal protein S20 |
|
affects expression |
ISO |
8 |
56,980,739 |
56,987,140 |
RGD:6480464 |
CTD |
| G |
RPS3A |
ribosomal protein S3A |
|
affects expression |
ISO |
4 |
152,020,725 |
152,025,804 |
RGD:6480464 |
CTD |
| G |
RPS6 |
ribosomal protein S6 |
|
affects expression |
ISO |
9 |
19,376,254 |
19,380,235 |
RGD:6480464 |
CTD |
| G |
RPS8 |
ribosomal protein S8 |
|
affects expression |
ISO |
1 |
45,241,246 |
45,244,412 |
RGD:6480464 |
CTD |
| G |
RRAS2 |
related RAS viral (r-ras) oncogene homolog 2 |
|
affects expression |
ISO |
11 |
14,299,466 |
14,386,052 |
RGD:6480464 |
CTD |
| G |
RUNDC3A |
RUN domain containing 3A |
|
increases expression |
EXP |
17 |
42,385,927 |
42,396,038 |
RGD:6480464 |
CTD |
| G |
S1PR1 |
sphingosine-1-phosphate receptor 1 |
|
affects expression |
ISO |
1 |
101,702,305 |
101,707,076 |
RGD:6480464 |
CTD |
| G |
SARDH |
sarcosine dehydrogenase |
|
increases expression |
EXP |
9 |
136,528,682 |
136,605,077 |
RGD:6480464 |
CTD |
| G |
SBSPON |
somatomedin B and thrombospondin, type 1 domain containing |
|
affects expression |
ISO |
8 |
73,976,778 |
74,005,507 |
RGD:6480464 |
CTD |
| G |
SCAND2P |
SCAN domain containing 2 pseudogene |
|
increases expression |
EXP |
15 |
85,174,691 |
85,185,694 |
RGD:6480464 |
CTD |
| G |
SCCPDH |
saccharopine dehydrogenase (putative) |
|
decreases expression |
ISO |
1 |
246,887,378 |
246,931,439 |
RGD:6480464 |
CTD |
| G |
SCD |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
multiple interactions |
EXP |
10 |
102,106,772 |
102,124,588 |
RGD:6480464 |
CTD |
| G |
SCD |
stearoyl-CoA desaturase (delta-9-desaturase) |
|
increases expression |
EXP |
10 |
102,106,772 |
102,124,588 |
RGD:6480464 |
CTD |
| G |
SCIMP |
SLP adaptor and CSK interacting membrane protein |
|
increases expression |
EXP |
17 |
5,113,901 |
5,138,083 |
RGD:6480464 |
CTD |
| G |
SCN1B |
sodium channel, voltage-gated, type I, beta subunit |
|
decreases expression |
ISO |
19 |
35,521,592 |
35,531,353 |
RGD:6480464 |
CTD |
| G |
SCN4A |
sodium channel, voltage-gated, type IV, alpha subunit |
|
decreases expression |
ISO |
17 |
62,015,914 |
62,050,278 |
RGD:6480464 |
CTD |
| G |
SCN5A |
sodium channel, voltage-gated, type V, alpha subunit |
|
decreases expression |
ISO |
3 |
38,589,553 |
38,691,164 |
RGD:6480464 |
CTD |
| G |
SDC2 |
syndecan 2 |
|
affects expression |
ISO |
8 |
97,505,882 |
97,624,037 |
RGD:6480464 |
CTD |
| G |
SDHC |
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa |
|
affects expression |
ISO |
1 |
161,284,166 |
161,334,541 |
RGD:6480464 |
CTD |
| G |
SDHD |
succinate dehydrogenase complex, subunit D, integral membrane protein |
|
affects expression |
ISO |
11 |
111,957,571 |
111,966,518 |
RGD:6480464 |
CTD |
| G |
SEMA3D |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D |
|
increases expression |
EXP |
7 |
84,624,869 |
84,751,247 |
RGD:6480464 |
CTD |
| G |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
|
increases expression |
EXP |
9 |
91,975,706 |
92,094,611 |
RGD:6480464 |
CTD |
| G |
SEMA6B |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B |
|
increases expression |
EXP |
19 |
4,542,600 |
4,559,771 |
RGD:6480464 |
CTD |
| G |
SEMG1 |
semenogelin I |
|
increases expression |
EXP |
20 |
43,835,638 |
43,838,414 |
RGD:6480464 |
CTD |
| G |
SERINC3 |
serine incorporator 3 |
|
affects expression |
ISO |
20 |
43,124,864 |
43,150,726 |
RGD:6480464 |
CTD |
| G |
SERPINA1 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
|
affects expression |
ISO |
14 |
94,843,084 |
94,857,029 |
RGD:6480464 |
CTD |
| G |
SERPINA10 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
|
increases expression |
EXP |
14 |
94,749,650 |
94,759,596 |
RGD:6480464 |
CTD |
| G |
SERPINA10 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 |
|
affects expression |
ISO |
14 |
94,749,650 |
94,759,596 |
RGD:6480464 |
CTD |
| G |
SERPINA4 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 |
|
affects expression |
ISO |
14 |
95,027,783 |
95,036,243 |
RGD:6480464 |
CTD |
| G |
SERPINA4 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 |
|
affects expression |
ISO |
14 |
95,027,783 |
95,036,243 |
RGD:6480464 |
CTD |
| G |
SERPINF2 |
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 |
|
affects expression |
ISO |
17 |
1,646,130 |
1,658,559 |
RGD:6480464 |
CTD |
| G |
SERTAD3 |
SERTA domain containing 3 |
|
increases expression |
EXP |
19 |
40,946,748 |
40,950,282 |
RGD:6480464 |
CTD |
| G |
SESN2 |
sestrin 2 |
|
increases expression |
EXP |
1 |
28,585,963 |
28,609,002 |
RGD:6480464 |
CTD |
| G |
SFXN1 |
sideroflexin 1 |
|
affects expression |
ISO |
5 |
174,905,514 |
174,955,621 |
RGD:6480464 |
CTD |
| G |
SH2D1A |
SH2 domain containing 1A |
|
increases expression |
EXP |
X |
123,480,132 |
123,507,010 |
RGD:6480464 |
CTD |
| G |
SH3GL3 |
SH3-domain GRB2-like 3 |
|
affects expression |
ISO |
15 |
84,116,091 |
84,287,495 |
RGD:6480464 |
CTD |
| G |
SHMT2 |
serine hydroxymethyltransferase 2 (mitochondrial) |
|
affects expression |
ISO |
12 |
57,623,356 |
57,628,718 |
RGD:6480464 |
CTD |
| G |
SIPA1L3 |
signal-induced proliferation-associated 1 like 3 |
|
increases expression |
EXP |
19 |
38,397,868 |
38,699,009 |
RGD:6480464 |
CTD |
| G |
SIRT4 |
sirtuin 4 |
|
increases expression |
EXP |
12 |
120,740,124 |
120,751,045 |
RGD:6480464 |
CTD |
| G |
SIX1 |
SIX homeobox 1 |
|
increases expression |
EXP |
14 |
61,111,417 |
61,116,155 |
RGD:6480464 |
CTD |
| G |
SLC13A4 |
solute carrier family 13 (sodium/sulfate symporters), member 4 |
|
increases expression |
EXP |
7 |
135,365,985 |
135,412,933 |
RGD:6480464 |
CTD |
| G |
SLC14A2 |
solute carrier family 14 (urea transporter), member 2 |
|
increases expression |
EXP |
18 |
42,792,947 |
43,263,072 |
RGD:6480464 |
CTD |
| G |
SLC22A1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
affects expression |
ISO |
6 |
160,542,863 |
160,579,750 |
RGD:6480464 |
CTD |
| G |
SLC23A1 |
solute carrier family 23 (nucleobase transporters), member 1 |
|
affects expression |
ISO |
5 |
138,702,885 |
138,719,039 |
RGD:6480464 |
CTD |
| G |
SLC25A13 |
solute carrier family 25 (aspartate/glutamate carrier), member 13 |
|
affects expression |
ISO |
7 |
95,749,532 |
95,951,459 |
RGD:6480464 |
CTD |
| G |
SLC25A18 |
solute carrier family 25 (glutamate carrier), member 18 |
|
increases expression |
EXP |
22 |
18,043,183 |
18,073,647 |
RGD:6480464 |
CTD |
| G |
SLC25A25 |
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
|
increases expression |
EXP |
9 |
130,830,479 |
130,871,537 |
RGD:6480464 |
CTD |
| G |
SLC25A26 |
solute carrier family 25 (S-adenosylmethionine carrier), member 26 |
|
increases expression |
EXP |
3 3 |
66,271,149 66,119,285 |
66,429,351 66,119,661 |
RGD:6480464 |
CTD |
| G |
SLC25A3 |
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 |
|
affects expression |
ISO |
12 |
98,987,403 |
98,995,778 |
RGD:6480464 |
CTD |
| G |
SLC25A30 |
solute carrier family 25, member 30 |
|
increases expression |
EXP |
13 |
45,967,451 |
45,992,516 |
RGD:6480464 |
CTD |
| G |
SLC26A4 |
solute carrier family 26, member 4 |
|
decreases expression |
EXP |
7 |
107,301,080 |
107,358,254 |
RGD:6480464 |
CTD |
| G |
SLC27A2 |
solute carrier family 27 (fatty acid transporter), member 2 |
|
affects expression |
ISO |
15 |
50,474,393 |
50,528,589 |
RGD:6480464 |
CTD |
| G |
SLC2A3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
decreases expression |
EXP |
12 |
8,071,824 |
8,088,892 |
RGD:6480464 |
CTD |
| G |
SLC30A1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
EXP |
1 |
211,748,381 |
211,752,099 |
RGD:6480464 |
CTD |
| G |
SLC35A2 |
solute carrier family 35 (UDP-galactose transporter), member A2 |
|
increases expression |
EXP |
X |
48,760,459 |
48,769,235 |
RGD:6480464 |
CTD |
| G |
SLC38A11 |
solute carrier family 38, member 11 |
|
increases expression |
EXP |
2 |
165,754,709 |
165,812,035 |
RGD:6480464 |
CTD |
| G |
SLC39A8 |
solute carrier family 39 (zinc transporter), member 8 |
|
affects expression |
ISO |
4 |
103,172,198 |
103,266,655 |
RGD:6480464 |
CTD |
| G |
SLC3A2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression |
EXP |
11 |
62,623,484 |
62,656,355 |
RGD:6480464 |
CTD |
| G |
SLC44A4 |
solute carrier family 44, member 4 |
|
decreases expression |
ISO |
6 |
31,830,969 |
31,846,823 |
RGD:6480464 |
CTD |
| G |
SLC46A1 |
solute carrier family 46 (folate transporter), member 1 |
|
affects expression |
ISO |
17 |
26,721,661 |
26,733,230 |
RGD:6480464 |
CTD |
| G |
SLC5A3 |
solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
|
increases expression |
EXP |
21 |
35,445,870 |
35,478,561 |
RGD:6480464 |
CTD |
| G |
SLC5A5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
|
decreases expression |
EXP |
19 |
17,982,782 |
18,005,983 |
RGD:6480464 |
CTD |
| G |
SLC6A6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
affects expression |
ISO |
3 |
14,444,106 |
14,530,857 |
RGD:6480464 |
CTD |
| G |
SLC8A1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
increases expression |
ISO |
2 |
40,339,286 |
40,739,575 |
RGD:6480464 |
CTD |
| G |
SLC8A3 |
solute carrier family 8 (sodium/calcium exchanger), member 3 |
|
decreases activity |
ISO |
14 |
70,510,934 |
70,655,787 |
RGD:6480464 |
CTD |
| G |
SLCO1A2 |
solute carrier organic anion transporter family, member 1A2 |
|
affects expression |
ISO |
12 |
21,417,534 |
21,548,371 |
RGD:6480464 |
CTD |
| G |
SLCO2B1 |
solute carrier organic anion transporter family, member 2B1 |
|
increases uptake |
EXP |
11 |
74,862,032 |
74,917,445 |
RGD:6480464 |
CTD |
| G |
SLCO4C1 |
solute carrier organic anion transporter family, member 4C1 |
|
increases expression |
EXP |
5 |
101,569,690 |
101,632,253 |
RGD:6480464 |
CTD |
| G |
SLCO5A1 |
solute carrier organic anion transporter family, member 5A1 |
|
increases expression |
EXP |
8 |
70,584,568 |
70,747,299 |
RGD:6480464 |
CTD |
| G |
SLFN5 |
schlafen family member 5 |
|
increases expression |
EXP |
17 |
33,570,086 |
33,594,768 |
RGD:6480464 |
CTD |
| G |
SLITRK3 |
SLIT and NTRK-like family, member 3 |
|
increases expression |
EXP |
3 |
164,904,508 |
164,914,469 |
RGD:6480464 |
CTD |
| G |
SLX4IP |
SLX4 interacting protein |
|
increases expression |
EXP |
20 |
10,415,951 |
10,604,027 |
RGD:6480464 |
CTD |
| G |
SMG6 |
smg-6 homolog, nonsense mediated mRNA decay factor (C. elegans) |
|
increases expression |
EXP |
17 |
1,963,133 |
2,207,069 |
RGD:6480464 |
CTD |
| G |
SMIM11 |
small integral membrane protein 11 |
|
increases expression |
EXP |
21 |
35,747,749 |
35,761,452 |
RGD:6480464 |
CTD |
| G |
SMOX |
spermine oxidase |
|
increases expression |
EXP |
20 |
4,129,426 |
4,168,394 |
RGD:6480464 |
CTD |
| G |
SNRNP35 |
small nuclear ribonucleoprotein 35kDa (U11/U12) |
|
increases expression |
EXP |
12 |
123,942,651 |
123,950,941 |
RGD:6480464 |
CTD |
| G |
SNX18 |
sorting nexin 18 |
|
increases expression |
EXP |
5 |
53,813,589 |
53,842,416 |
RGD:6480464 |
CTD |
| G |
SOCS6 |
suppressor of cytokine signaling 6 |
|
increases expression |
EXP |
18 |
67,956,137 |
67,997,434 |
RGD:6480464 |
CTD |
| G |
SPAG1 |
sperm associated antigen 1 |
|
increases expression |
EXP |
8 |
101,170,263 |
101,254,132 |
RGD:6480464 |
CTD |
| G |
SPATA17 |
spermatogenesis associated 17 |
|
increases expression |
EXP |
1 |
217,804,695 |
218,040,484 |
RGD:6480464 |
CTD |
| G |
SPATA2L |
spermatogenesis associated 2-like |
|
increases expression |
EXP |
16 |
89,762,765 |
89,768,121 |
RGD:6480464 |
CTD |
| G |
SPEF2 |
sperm flagellar 2 |
|
increases expression |
EXP |
5 |
35,617,989 |
35,814,713 |
RGD:6480464 |
CTD |
| G |
SPHAR |
S-phase response (cyclin related) |
|
increases expression |
EXP |
1 |
229,440,129 |
229,441,251 |
RGD:6480464 |
CTD |
| G |
SPOPL |
speckle-type POZ protein-like |
|
increases expression |
EXP |
2 |
139,259,350 |
139,330,805 |
RGD:6480464 |
CTD |
| G |
SPPL2A |
signal peptide peptidase like 2A |
|
affects expression |
ISO |
15 |
50,999,730 |
51,057,910 |
RGD:6480464 |
CTD |
| G |
SPR |
sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase) |
|
increases expression |
EXP |
2 |
73,114,512 |
73,119,289 |
RGD:6480464 |
CTD |
| G |
SPTBN1 |
spectrin, beta, non-erythrocytic 1 |
|
increases expression |
EXP |
2 |
54,683,454 |
54,898,583 |
RGD:6480464 |
CTD |
| G |
SQSTM1 |
sequestosome 1 |
|
increases expression |
EXP |
5 |
179,233,388 |
179,265,078 |
RGD:6480464 |
CTD |
| G |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
|
decreases expression |
ISO |
17 |
17,714,663 |
17,740,325 |
RGD:6480464 |
CTD |
| G |
SREK1IP1 |
SREK1-interacting protein 1 |
|
increases expression |
EXP |
5 |
64,013,975 |
64,064,496 |
RGD:6480464 |
CTD |
| G |
SRM |
spermidine synthase |
|
affects expression |
ISO |
1 |
11,114,649 |
11,120,091 |
RGD:6480464 |
CTD |
| G |
SRPRB |
signal recognition particle receptor, B subunit |
|
affects expression |
ISO |
3 |
133,502,877 |
133,540,336 |
RGD:6480464 |
CTD |
| G |
SS18L1 |
synovial sarcoma translocation gene on chromosome 18-like 1 |
|
increases expression |
EXP |
20 |
60,718,822 |
60,757,566 |
RGD:6480464 |
CTD |
| G |
SSX2IP |
synovial sarcoma, X breakpoint 2 interacting protein |
|
affects expression |
ISO |
1 |
85,109,390 |
85,156,240 |
RGD:6480464 |
CTD |
| G |
ST13 |
suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) |
|
affects expression |
ISO |
22 |
41,220,599 |
41,252,687 |
RGD:6480464 |
CTD |
| G |
ST3GAL6 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
|
affects expression |
ISO |
3 |
98,451,080 |
98,514,689 |
RGD:6480464 |
CTD |
| G |
ST6GAL1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
affects expression |
ISO |
3 |
186,648,315 |
186,796,341 |
RGD:6480464 |
CTD |
| G |
STARD5 |
StAR-related lipid transfer (START) domain containing 5 |
|
increases expression |
EXP |
15 |
81,605,007 |
81,616,524 |
RGD:6480464 |
CTD |
| G |
STBD1 |
starch binding domain 1 |
|
affects expression |
ISO |
4 |
77,227,179 |
77,232,283 |
RGD:6480464 |
CTD |
| G |
STK16 |
serine/threonine kinase 16 |
|
increases expression |
EXP |
2 |
220,110,192 |
220,115,059 |
RGD:6480464 |
CTD |
| G |
STMN1 |
stathmin 1 |
|
affects expression |
ISO |
1 |
26,210,677 |
26,233,368 |
RGD:6480464 |
CTD |
| G |
STX11 |
syntaxin 11 |
|
increases expression |
EXP |
6 |
144,471,654 |
144,513,076 |
RGD:6480464 |
CTD |
| G |
STXBP2 |
syntaxin binding protein 2 |
|
increases expression |
EXP |
19 |
7,701,991 |
7,712,759 |
RGD:6480464 |
CTD |
| G |
SUCLG1 |
succinate-CoA ligase, alpha subunit |
|
affects expression |
ISO |
2 |
84,650,647 |
84,686,586 |
RGD:6480464 |
CTD |
| G |
SULT1A3 |
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 |
|
increases expression |
EXP |
16 |
30,210,549 |
30,215,650 |
RGD:6480464 |
CTD |
| G |
SURF4 |
surfeit 4 |
|
affects expression |
ISO |
9 |
136,228,340 |
136,242,970 |
RGD:6480464 |
CTD |
| G |
SVIL |
supervillin |
|
increases expression |
EXP |
10 |
29,746,277 |
30,024,730 |
RGD:6480464 |
CTD |
| G |
SYNJ2BP |
synaptojanin 2 binding protein |
|
affects expression |
ISO |
14 |
70,833,213 |
70,883,807 |
RGD:6480464 |
CTD |
| G |
TAF5L |
TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa |
|
increases expression |
EXP |
1 |
229,728,858 |
229,761,794 |
RGD:6480464 |
CTD |
| G |
TAGLN |
transgelin |
|
decreases expression |
EXP |
11 |
117,070,040 |
117,075,508 |
RGD:6480464 |
CTD |
| G |
TAPBPL |
TAP binding protein-like |
|
increases expression |
EXP |
12 |
6,561,177 |
6,571,488 |
RGD:6480464 |
CTD |
| G |
TAS2R10 |
taste receptor, type 2, member 10 |
|
increases expression |
EXP |
12 |
10,977,945 |
10,978,868 |
RGD:6480464 |
CTD |
| G |
TAZ |
tafazzin |
|
increases expression |
EXP |
X |
153,639,877 |
153,650,065 |
RGD:6480464 |
CTD |
| G |
TBC1D3 |
TBC1 domain family, member 3 |
|
increases expression |
EXP |
17 |
36,337,528 |
36,348,666 |
RGD:6480464 |
CTD |
| G |
TBX4 |
T-box 4 |
|
increases expression |
EXP |
17 |
59,533,807 |
59,561,664 |
RGD:6480464 |
CTD |
| G |
TCAIM |
T cell activation inhibitor, mitochondrial |
|
increases expression |
EXP |
3 |
44,379,611 |
44,450,940 |
RGD:6480464 |
CTD |
| G |
TCF20 |
transcription factor 20 (AR1) |
|
increases expression |
EXP |
22 |
42,556,019 |
42,611,445 |
RGD:6480464 |
CTD |
| G |
TCF7 |
transcription factor 7 (T-cell specific, HMG-box) |
|
increases expression |
EXP |
5 |
133,450,402 |
133,483,920 |
RGD:6480464 |
CTD |
| G |
TCL1B |
T-cell leukemia/lymphoma 1B |
|
increases expression |
EXP |
14 |
96,152,754 |
96,158,980 |
RGD:6480464 |
CTD |
| G |
TDO2 |
tryptophan 2,3-dioxygenase |
|
increases expression |
EXP |
4 |
156,824,845 |
156,841,558 |
RGD:6480464 |
CTD |
| G |
TEF |
thyrotrophic embryonic factor |
|
increases expression |
EXP |
22 |
41,763,337 |
41,795,332 |
RGD:6480464 |
CTD |
| G |
TERF1 |
telomeric repeat binding factor (NIMA-interacting) 1 |
|
increases expression |
EXP |
8 |
73,921,097 |
73,959,987 |
RGD:6480464 |
CTD |
| G |
TEX261 |
testis expressed 261 |
|
affects expression |
ISO |
2 |
71,213,068 |
71,222,001 |
RGD:6480464 |
CTD |
| G |
TF |
transferrin |
|
decreases expression |
ISO |
3 |
133,464,977 |
133,497,850 |
RGD:6480464 |
CTD |
| G |
TFAP2C |
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) |
|
increases expression |
EXP |
20 |
55,204,358 |
55,214,339 |
RGD:6480464 |
CTD |
| G |
TFG |
TRK-fused gene |
|
increases expression |
EXP |
3 |
100,428,134 |
100,467,811 |
RGD:6480464 |
CTD |
| G |
TG |
thyroglobulin |
|
decreases expression |
EXP |
8 |
133,879,205 |
134,147,143 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
increases expression |
ISO |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
|
affects expression |
ISO |
5 |
135,364,584 |
135,399,507 |
RGD:6480464 |
CTD |
| G |
TGFBI |
transforming growth factor, beta-induced, 68kDa |
|
affects expression |
ISO |
5 |
135,364,584 |
135,399,507 |
RGD:6480464 |
CTD |
| G |
THNSL2 |
threonine synthase-like 2 (S. cerevisiae) |
|
affects expression |
ISO |
2 |
88,469,814 |
88,486,156 |
RGD:6480464 |
CTD |
| G |
THRA |
thyroid hormone receptor, alpha |
|
affects binding |
EXP |
17 |
38,218,446 |
38,250,120 |
RGD:6480464 |
CTD |
| G |
THRA |
thyroid hormone receptor, alpha |
|
decreases expression |
ISO |
17 |
38,218,446 |
38,250,120 |
RGD:6480464 |
CTD |
| G |
THRA |
thyroid hormone receptor, alpha |
|
decreases expression |
ISO |
17 |
38,218,446 |
38,250,120 |
RGD:6480464 |
CTD |
| G |
THRA |
thyroid hormone receptor, alpha |
|
increases expression |
ISO |
17 |
38,218,446 |
38,250,120 |
RGD:6480464 |
CTD |
| G |
THRA |
thyroid hormone receptor, alpha |
|
multiple interactions |
ISO |
17 |
38,218,446 |
38,250,120 |
RGD:6480464 |
CTD |
| G |
THRB |
thyroid hormone receptor, beta |
|
affects binding |
EXP |
3 |
24,158,644 |
24,536,313 |
RGD:6480464 |
CTD |
| G |
THRB |
thyroid hormone receptor, beta |
|
increases expression |
EXP |
3 |
24,158,644 |
24,536,313 |
RGD:6480464 |
CTD |
| G |
THRB |
thyroid hormone receptor, beta |
|
multiple interactions |
ISO |
3 |
24,158,644 |
24,536,313 |
RGD:6480464 |
CTD |
| G |
THRB |
thyroid hormone receptor, beta |
|
decreases expression |
ISO |
3 |
24,158,644 |
24,536,313 |
RGD:6480464 |
CTD |
| G |
THRB |
thyroid hormone receptor, beta |
|
decreases expression |
ISO |
3 |
24,158,644 |
24,536,313 |
RGD:6480464 |
CTD |
| G |
THRSP |
thyroid hormone responsive |
|
increases expression |
ISO |
11 |
77,774,907 |
77,779,403 |
RGD:6480464 |
CTD |
| G |
THRSP |
thyroid hormone responsive |
|
multiple interactions |
ISO |
11 |
77,774,907 |
77,779,403 |
RGD:6480464 |
CTD |
| G |
TIGD6 |
tigger transposable element derived 6 |
|
increases expression |
EXP |
5 |
149,372,686 |
149,380,730 |
RGD:6480464 |
CTD |
| G |
TIMM10B |
translocase of inner mitochondrial membrane 10 homolog B (yeast) |
|
affects expression |
ISO |
11 |
6,502,677 |
6,505,911 |
RGD:6480464 |
CTD |
| G |
TIMM13 |
translocase of inner mitochondrial membrane 13 homolog (yeast) |
|
increases expression |
EXP |
19 |
2,425,622 |
2,427,875 |
RGD:6480464 |
CTD |
| G |
TIMM17A |
translocase of inner mitochondrial membrane 17 homolog A (yeast) |
|
increases expression |
EXP |
1 |
201,924,619 |
201,939,789 |
RGD:6480464 |
CTD |
| G |
TIMM21 |
translocase of inner mitochondrial membrane 21 homolog (yeast) |
|
affects expression |
ISO |
18 |
71,815,746 |
71,826,204 |
RGD:6480464 |
CTD |
| G |
TINAG |
tubulointerstitial nephritis antigen |
|
increases expression |
EXP |
6 |
54,173,203 |
54,254,950 |
RGD:6480464 |
CTD |
| G |
TJP3 |
tight junction protein 3 |
|
decreases expression |
ISO |
19 |
3,708,335 |
3,750,811 |
RGD:6480464 |
CTD |
| G |
TKTL1 |
transketolase-like 1 |
|
increases expression |
EXP |
X |
153,524,027 |
153,558,713 |
RGD:6480464 |
CTD |
| G |
TLCD1 |
TLC domain containing 1 |
|
decreases expression |
ISO |
17 |
27,051,366 |
27,053,949 |
RGD:6480464 |
CTD |
| G |
TMBIM1 |
transmembrane BAX inhibitor motif containing 1 |
|
affects expression |
ISO |
2 |
219,138,917 |
219,157,280 |
RGD:6480464 |
CTD |
| G |
TMCC2 |
transmembrane and coiled-coil domain family 2 |
|
increases expression |
EXP |
1 |
205,197,038 |
205,242,471 |
RGD:6480464 |
CTD |
| G |
TMCO1 |
transmembrane and coiled-coil domains 1 |
|
affects expression |
ISO |
1 |
165,693,528 |
165,738,159 |
RGD:6480464 |
CTD |
| G |
TMED2 |
transmembrane emp24 domain trafficking protein 2 |
|
affects expression |
ISO |
12 |
124,069,076 |
124,082,688 |
RGD:6480464 |
CTD |
| G |
TMED7 |
transmembrane emp24 protein transport domain containing 7 |
|
affects expression |
ISO |
5 |
114,948,905 |
114,961,876 |
RGD:6480464 |
CTD |
| G |
TMED7 |
transmembrane emp24 protein transport domain containing 7 |
|
affects expression |
ISO |
5 |
114,948,905 |
114,961,876 |
RGD:6480464 |
CTD |
| G |
TMEM123 |
transmembrane protein 123 |
|
affects expression |
ISO |
11 |
102,267,056 |
102,323,775 |
RGD:6480464 |
CTD |
| G |
TMEM161B |
transmembrane protein 161B |
|
increases expression |
EXP |
5 |
87,491,023 |
87,564,665 |
RGD:6480464 |
CTD |
| G |
TMEM31 |
transmembrane protein 31 |
|
increases expression |
EXP |
X |
102,965,837 |
102,968,960 |
RGD:6480464 |
CTD |
| G |
TMEM68 |
transmembrane protein 68 |
|
increases expression |
EXP |
8 |
56,651,320 |
56,685,885 |
RGD:6480464 |
CTD |
| G |
TMEM97 |
transmembrane protein 97 |
|
affects expression |
ISO |
17 |
26,646,121 |
26,655,711 |
RGD:6480464 |
CTD |
| G |
TMLHE |
trimethyllysine hydroxylase, epsilon |
|
increases expression |
EXP |
X |
154,718,672 |
154,842,622 |
RGD:6480464 |
CTD |
| G |
TMPRSS9 |
transmembrane protease, serine 9 |
|
increases expression |
EXP |
19 |
2,389,784 |
2,426,086 |
RGD:6480464 |
CTD |
| G |
TMUB2 |
transmembrane and ubiquitin-like domain containing 2 |
|
increases expression |
EXP |
17 |
42,264,354 |
42,269,099 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNFAIP3 |
tumor necrosis factor, alpha-induced protein 3 |
|
increases expression |
EXP |
6 |
138,188,325 |
138,204,451 |
RGD:6480464 |
CTD |
| G |
TNFRSF10B |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
EXP |
8 |
22,877,646 |
22,926,700 |
RGD:6480464 |
CTD |
| G |
TNFRSF10B |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
EXP |
8 |
22,877,646 |
22,926,700 |
RGD:6480464 |
CTD |
| G |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases response to substance |
EXP |
3 |
172,223,298 |
172,241,297 |
RGD:6480464 |
CTD |
| G |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
EXP |
3 |
172,223,298 |
172,241,297 |
RGD:6480464 |
CTD |
| G |
TNNT1 |
troponin T type 1 (skeletal, slow) |
|
increases expression |
EXP |
19 |
55,644,161 |
55,660,606 |
RGD:6480464 |
CTD |
| G |
TNRC6A |
trinucleotide repeat containing 6A |
|
increases expression |
EXP |
16 |
24,741,049 |
24,837,548 |
RGD:6480464 |
CTD |
| G |
TOM1L1 |
target of myb1 (chicken)-like 1 |
|
increases expression |
EXP |
17 |
52,978,052 |
53,039,328 |
RGD:6480464 |
CTD |
| G |
TPO |
thyroid peroxidase |
|
decreases expression |
EXP |
2 |
1,417,233 |
1,546,499 |
RGD:6480464 |
CTD |
| G |
TREX1 |
three prime repair exonuclease 1 |
|
increases expression |
EXP |
3 |
48,506,919 |
48,509,044 |
RGD:6480464 |
CTD |
| G |
TRIB3 |
tribbles homolog 3 (Drosophila) |
|
increases expression |
EXP |
20 |
361,308 |
378,203 |
RGD:6480464 |
CTD |
| G |
TRIM36 |
tripartite motif containing 36 |
|
increases expression |
EXP |
5 |
114,460,459 |
114,516,243 |
RGD:6480464 |
CTD |
| G |
TRIM61 |
tripartite motif containing 61 |
|
increases expression |
EXP |
4 |
165,875,598 |
165,898,818 |
RGD:6480464 |
CTD |
| G |
TRMT10B |
tRNA methyltransferase 10 homolog B (S. cerevisiae) |
|
increases expression |
EXP |
9 |
37,753,802 |
37,778,969 |
RGD:6480464 |
CTD |
| G |
TRNT1 |
tRNA nucleotidyl transferase, CCA-adding, 1 |
|
increases expression |
EXP |
3 |
3,168,600 |
3,190,707 |
RGD:6480464 |
CTD |
| G |
TRPV2 |
transient receptor potential cation channel, subfamily V, member 2 |
|
increases expression |
EXP |
17 |
16,318,856 |
16,340,317 |
RGD:6480464 |
CTD |
| G |
TSGA10 |
testis specific, 10 |
|
increases expression |
EXP |
2 |
99,613,724 |
99,771,187 |
RGD:6480464 |
CTD |
| G |
TSHB |
thyroid stimulating hormone, beta |
|
increases expression |
EXP |
1 |
115,572,415 |
115,576,941 |
RGD:6480464 |
CTD |
| G |
TSHB |
thyroid stimulating hormone, beta |
|
increases expression |
ISO |
1 |
115,572,415 |
115,576,941 |
RGD:6480464 |
CTD |
| G |
TSHB |
thyroid stimulating hormone, beta |
|
increases expression |
ISO |
1 |
115,572,415 |
115,576,941 |
RGD:6480464 |
CTD |
| G |
TSLP |
thymic stromal lymphopoietin |
|
increases expression |
EXP |
5 |
110,405,778 |
110,413,722 |
RGD:6480464 |
CTD |
| G |
TSPYL2 |
TSPY-like 2 |
|
increases expression |
EXP |
X |
53,111,542 |
53,117,728 |
RGD:6480464 |
CTD |
| G |
TTBK2 |
tau tubulin kinase 2 |
|
increases expression |
EXP |
15 |
43,036,536 |
43,213,007 |
RGD:6480464 |
CTD |
| G |
TTLL3 |
tubulin tyrosine ligase-like family, member 3 |
|
increases expression |
EXP |
3 |
9,851,644 |
9,878,040 |
RGD:6480464 |
CTD |
| G |
TUSC3 |
tumor suppressor candidate 3 |
|
increases expression |
EXP |
8 |
15,397,596 |
15,624,158 |
RGD:6480464 |
CTD |
| G |
TXN |
thioredoxin |
|
affects expression |
ISO |
9 |
113,006,092 |
113,018,920 |
RGD:6480464 |
CTD |
| G |
TXNL1 |
thioredoxin-like 1 |
|
affects expression |
ISO |
18 |
54,270,053 |
54,305,920 |
RGD:6480464 |
CTD |
| G |
UBA52 |
ubiquitin A-52 residue ribosomal protein fusion product 1 |
|
affects expression |
ISO |
19 |
18,682,614 |
18,688,270 |
RGD:6480464 |
CTD |
| G |
UBE2D2 |
ubiquitin-conjugating enzyme E2D 2 |
|
increases expression |
EXP |
5 |
138,940,751 |
139,008,019 |
RGD:6480464 |
CTD |
| G |
UBE2D3 |
ubiquitin-conjugating enzyme E2D 3 |
|
increases expression |
EXP |
4 |
103,717,133 |
103,790,032 |
RGD:6480464 |
CTD |
| G |
UBE2N |
ubiquitin-conjugating enzyme E2N |
|
affects expression |
ISO |
12 |
93,802,088 |
93,836,026 |
RGD:6480464 |
CTD |
| G |
UBXN10 |
UBX domain protein 10 |
|
increases expression |
EXP |
1 |
20,512,578 |
20,519,942 |
RGD:6480464 |
CTD |
| G |
UBXN11 |
UBX domain protein 11 |
|
increases expression |
EXP |
1 |
26,608,773 |
26,644,756 |
RGD:6480464 |
CTD |
| G |
UFD1L |
ubiquitin fusion degradation 1 like (yeast) |
|
affects expression |
ISO |
22 |
19,437,464 |
19,466,738 |
RGD:6480464 |
CTD |
| G |
UGT1A1 |
UDP glucuronosyltransferase 1 family, polypeptide A1 |
|
affects expression |
ISO |
2 |
234,668,919 |
234,681,945 |
RGD:6480464 |
CTD |
| G |
UGT2A1 |
UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus |
|
affects expression |
ISO |
4 |
70,454,135 |
70,518,967 |
RGD:6480464 |
CTD |
| G |
UGT2B28 |
UDP glucuronosyltransferase 2 family, polypeptide B28 |
|
affects expression |
ISO |
4 |
70,146,217 |
70,160,768 |
RGD:6480464 |
CTD |
| G |
UGT2B4 |
UDP glucuronosyltransferase 2 family, polypeptide B4 |
|
affects expression |
ISO |
4 |
70,345,883 |
70,361,626 |
RGD:6480464 |
CTD |
| G |
UHRF1BP1L |
UHRF1 binding protein 1-like |
|
affects expression |
ISO |
12 |
100,430,863 |
100,536,642 |
RGD:6480464 |
CTD |
| G |
ULK3 |
unc-51-like kinase 3 (C. elegans) |
|
increases expression |
EXP |
15 |
75,128,459 |
75,135,552 |
RGD:6480464 |
CTD |
| G |
UQCR11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
|
affects expression |
ISO |
19 |
1,597,154 |
1,605,483 |
RGD:6480464 |
CTD |
| G |
UQCR11 |
ubiquinol-cytochrome c reductase, complex III subunit XI |
|
affects expression |
ISO |
19 |
1,597,154 |
1,605,483 |
RGD:6480464 |
CTD |
| G |
USF1 |
upstream transcription factor 1 |
|
increases expression |
EXP |
1 |
161,009,041 |
161,015,757 |
RGD:6480464 |
CTD |
| G |
USP2 |
ubiquitin specific peptidase 2 |
|
increases expression |
EXP |
11 |
119,225,925 |
119,252,436 |
RGD:6480464 |
CTD |
| G |
USP25 |
ubiquitin specific peptidase 25 |
|
increases expression |
EXP |
21 |
17,102,496 |
17,252,377 |
RGD:6480464 |
CTD |
| G |
UTS2 |
urotensin 2 |
|
increases expression |
EXP |
1 |
7,907,672 |
7,913,551 |
RGD:6480464 |
CTD |
| G |
VCAM1 |
vascular cell adhesion molecule 1 |
|
increases expression |
EXP |
1 |
101,185,196 |
101,204,601 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
increases expression |
EXP |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VMAC |
vimentin-type intermediate filament associated coiled-coil protein |
|
increases expression |
EXP |
19 |
5,904,852 |
5,910,263 |
RGD:6480464 |
CTD |
| G |
VNN1 |
vanin 1 |
|
affects expression |
ISO |
6 |
133,001,997 |
133,035,194 |
RGD:6480464 |
CTD |
| G |
VPS11 |
vacuolar protein sorting 11 homolog (S. cerevisiae) |
|
increases expression |
EXP |
11 |
118,938,493 |
118,952,688 |
RGD:6480464 |
CTD |
| G |
VPS13B |
vacuolar protein sorting 13 homolog B (yeast) |
|
increases expression |
EXP |
8 |
100,025,494 |
100,889,814 |
RGD:6480464 |
CTD |
| G |
VPS16 |
vacuolar protein sorting 16 homolog (S. cerevisiae) |
|
increases expression |
EXP |
20 |
2,821,373 |
2,847,378 |
RGD:6480464 |
CTD |
| G |
VWA1 |
von Willebrand factor A domain containing 1 |
|
decreases expression |
ISO |
1 |
1,370,903 |
1,378,262 |
RGD:6480464 |
CTD |
| G |
WBSCR16 |
Williams-Beuren syndrome chromosome region 16 |
|
increases expression |
EXP |
7 |
74,456,283 |
74,489,699 |
RGD:6480464 |
CTD |
| G |
WBSCR17 |
Williams-Beuren syndrome chromosome region 17 |
|
increases expression |
EXP |
7 |
70,597,789 |
71,178,584 |
RGD:6480464 |
CTD |
| G |
WDR26 |
WD repeat domain 26 |
|
affects expression |
ISO |
1 |
224,572,845 |
224,622,001 |
RGD:6480464 |
CTD |
| G |
WIPI1 |
WD repeat domain, phosphoinositide interacting 1 |
|
increases expression |
EXP |
17 |
66,417,422 |
66,453,653 |
RGD:6480464 |
CTD |
| G |
WNK1 |
WNK lysine deficient protein kinase 1 |
|
increases expression |
EXP |
12 |
862,089 |
1,020,618 |
RGD:6480464 |
CTD |
| G |
WTAP |
Wilms tumor 1 associated protein |
|
increases expression |
EXP |
6 |
160,148,030 |
160,177,351 |
RGD:6480464 |
CTD |
| G |
XBP1 |
X-box binding protein 1 |
|
increases expression |
EXP |
22 |
29,190,548 |
29,196,560 |
RGD:6480464 |
CTD |
| G |
XK |
X-linked Kx blood group (McLeod syndrome) |
|
increases expression |
EXP |
X |
37,545,133 |
37,591,383 |
RGD:6480464 |
CTD |
| G |
XPNPEP2 |
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound |
|
increases expression |
EXP |
X |
128,872,946 |
128,903,525 |
RGD:6480464 |
CTD |
| G |
XPO7 |
exportin 7 |
|
decreases expression |
ISO |
8 |
21,777,180 |
21,864,096 |
RGD:6480464 |
CTD |
| G |
XPO7 |
exportin 7 |
|
decreases expression |
ISO |
8 |
21,777,180 |
21,864,096 |
RGD:6480464 |
CTD |
| G |
YWHAG |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
|
affects expression |
ISO |
7 |
75,956,108 |
75,988,342 |
RGD:6480464 |
CTD |
| G |
ZBED3 |
zinc finger, BED-type containing 3 |
|
increases expression |
EXP |
5 |
76,372,532 |
76,383,030 |
RGD:6480464 |
CTD |
| G |
ZBTB49 |
zinc finger and BTB domain containing 49 |
|
increases expression |
EXP |
4 |
4,291,924 |
4,323,513 |
RGD:6480464 |
CTD |
| G |
ZC3HAV1 |
zinc finger CCCH-type, antiviral 1 |
|
increases expression |
EXP |
7 |
138,728,266 |
138,794,465 |
RGD:6480464 |
CTD |
| G |
ZDHHC15 |
zinc finger, DHHC-type containing 15 |
|
increases expression |
EXP |
X |
74,588,262 |
74,743,337 |
RGD:6480464 |
CTD |
| G |
ZDHHC23 |
zinc finger, DHHC-type containing 23 |
|
affects expression |
ISO |
3 |
113,666,748 |
113,681,829 |
RGD:6480464 |
CTD |
| G |
ZFP36 |
ZFP36 ring finger protein |
|
increases expression |
EXP |
19 |
39,897,487 |
39,900,052 |
RGD:6480464 |
CTD |
| G |
ZMYND10 |
zinc finger, MYND-type containing 10 |
|
increases expression |
EXP |
3 |
50,378,537 |
50,383,156 |
RGD:6480464 |
CTD |
| G |
ZNF101 |
zinc finger protein 101 |
|
increases expression |
EXP |
19 |
19,779,663 |
19,791,138 |
RGD:6480464 |
CTD |
| G |
ZNF121 |
zinc finger protein 121 |
|
increases expression |
EXP |
19 |
9,676,292 |
9,695,209 |
RGD:6480464 |
CTD |
| G |
ZNF197 |
zinc finger protein 197 |
|
increases expression |
EXP |
3 |
44,666,511 |
44,689,963 |
RGD:6480464 |
CTD |
| G |
ZNF205 |
zinc finger protein 205 |
|
increases expression |
EXP |
16 |
3,162,563 |
3,170,518 |
RGD:6480464 |
CTD |
| G |
ZNF225 |
zinc finger protein 225 |
|
increases expression |
EXP |
19 |
44,617,548 |
44,637,255 |
RGD:6480464 |
CTD |
| G |
ZNF311 |
zinc finger protein 311 |
|
increases expression |
EXP |
6 |
28,962,594 |
28,973,037 |
RGD:6480464 |
CTD |
| G |
ZNF420 |
zinc finger protein 420 |
|
increases expression |
EXP |
19 |
37,569,382 |
37,620,662 |
RGD:6480464 |
CTD |
| G |
ZNF497 |
zinc finger protein 497 |
|
increases expression |
EXP |
19 |
58,865,723 |
58,874,214 |
RGD:6480464 |
CTD |
| G |
ZNF554 |
zinc finger protein 554 |
|
increases expression |
EXP |
19 |
2,819,872 |
2,836,733 |
RGD:6480464 |
CTD |
| G |
ZNF584 |
zinc finger protein 584 |
|
increases expression |
EXP |
19 |
58,920,063 |
58,929,694 |
RGD:6480464 |
CTD |
| G |
ZNF592 |
zinc finger protein 592 |
|
increases expression |
EXP |
15 |
85,291,818 |
85,349,663 |
RGD:6480464 |
CTD |
| G |
ZNF624 |
zinc finger protein 624 |
|
increases expression |
EXP |
17 |
16,524,048 |
16,557,167 |
RGD:6480464 |
CTD |
| G |
ZNF683 |
zinc finger protein 683 |
|
increases expression |
EXP |
1 |
26,688,125 |
26,699,266 |
RGD:6480464 |
CTD |
| G |
ZNF703 |
zinc finger protein 703 |
|
increases expression |
EXP |
8 |
37,553,301 |
37,556,396 |
RGD:6480464 |
CTD |
| G |
ZNF704 |
zinc finger protein 704 |
|
increases expression |
EXP |
8 |
81,540,686 |
81,787,016 |
RGD:6480464 |
CTD |
| G |
ZNF710 |
zinc finger protein 710 |
|
increases expression |
EXP |
15 |
90,544,752 |
90,625,432 |
RGD:6480464 |
CTD |
| G |
ZNF771 |
zinc finger protein 771 |
|
increases expression |
EXP |
16 |
30,418,735 |
30,429,916 |
RGD:6480464 |
CTD |
| G |
ZNHIT2 |
zinc finger, HIT-type containing 2 |
|
increases expression |
EXP |
11 |
64,883,875 |
64,885,170 |
RGD:6480464 |
CTD |
| G |
ZSCAN20 |
zinc finger and SCAN domain containing 20 |
|
increases expression |
EXP |
1 |
33,938,232 |
33,961,995 |
RGD:6480464 |
CTD |
| G |
ZWINT |
ZW10 interactor, kinetochore protein |
|
affects expression |
ISO |
10 |
58,117,199 |
58,121,034 |
RGD:6480464 |
CTD |
| G |
ZXDA |
zinc finger, X-linked, duplicated A |
|
increases expression |
EXP |
X |
57,931,864 |
57,937,067 |
RGD:6480464 |
CTD |
Term paths to the root
|